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ABSTRACT OF DISSERTATION 
 
 
 
 
FACTORS INFLUENCING PREFERENCE FOR SURGICAL CHOICE AMONG 
WOMEN WITH EARLY STAGE BREAST CANCER 
 
Breast cancer is the most common cancer among women in the United States with 
over 60% of cases diagnosed as early stage disease. For those women without prohibiting 
clinical or cosmetic concerns, a choice between breast-conserving surgery and 
mastectomy can be made. Either choice confers equivalent survival. The decision-making 
process also involves consideration of recurrence risk as well as management of the 
unaffected, contralateral breast for both future surveillance and risk reduction. In recent 
years, increasing rates of mastectomy with contralateral prophylactic mastectomy have 
been reported among women with unilateral, early stage breast cancer. If eligible for a 
choice among surgical options, a woman’s decision becomes one of personal preference.  
The decision-making process is complex and involves consideration of potential benefits 
and harms with each option.  
The purpose of this dissertation was to: 1) analyze the psychometric properties of 
the Anxiety Subscale of the Depression Anxiety Stress Scale, 2) critically review 
Decisional Conflict Scales and 3) prospectively identify demographic, clinical, cognitive 
and affective factors influencing a woman’s decision to choose either breast conserving 
surgery or mastectomy with contralateral prophylactic mastectomy and to identify self-
reported sources of information in the surgical decision-making process.  
Three manuscripts make up the dissertation. A secondary data analysis was 
conducted to test the psychometric properties of the Anxiety Subscale of the Depression 
Anxiety Stress Scale (DASS). The results of this analysis supported the reliability and 
validity of the DASS anxiety subscale. A critical review of decisional conflict measures 
for use with early stage breast cancer patients making surgical treatment decisions was 
conducted. The results of this review supported the use of Decisional Conflict Scales 
from a clinical and research perspective. Existing Decisional Conflict Scales show 
moderate to acceptable reliability.  
The first two manuscripts provided background and support for the use of scales 
included in the research study described in the third manuscript. This study was a 
prospective, exploratory, cross-sectional, mixed-methods study describing factors 
influencing preference for surgical choice among women with early stage breast cancer.  
A sample of 78 participants enrolled in the study, 47 who chose breast conserving 
surgery and 31 who chose mastectomy with contralateral prophylactic mastectomy. 
 
 
Differences were tested between the groups. Women who chose mastectomy with 
contralateral prophylactic mastectomy were younger, more likely to work full or part-
time, had larger tumors and participated in preoperative genetic counselling. Women who 
chose breast conserving surgery were more likely to have participated in preoperative 
breast magnetic resonance imaging. Overall, women choosing either surgery were not 
experiencing severe levels of distress, depression, anxiety or stress although there were 
individual variations.  Women choosing mastectomy with contralateral prophylactic 
mastectomy were more anxious and had more frequent intrusive thoughts about the 
diagnosis.  They also had less decisional conflict as compared to women choosing breast 
conserving surgery.  Information sources were similar but the most influential 
information source differed among the two groups. In both groups, intention for surgical 
choice was matched by the final decision.  There are many factors influencing surgical 
choice among women with early stage breast cancer.  Previous work has focused on 
clinical, demographic and diagnostic processes influencing the decision.  With this study, 
evidence regarding the influence of cognitive and affective factors is described. 
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CHAPTER ONE: 
Introduction 
1.1. Breast Cancer and Surgical Treatment 
Breast cancer continues to be the cancer of highest incidence among women in 
the United States with 252,710 new cases projected in 2017 (Siegel, Miller, & Jemal, 
2017). Declining mortality rates due to early detection and treatment advances have been 
noted since the 1990’s yet breast cancer remains the second leading cause of cancer-
related death among women (DeSantis, Ma, Bryan, & Jemal, 2014).  The majority of 
breast cancer cases present as localized or early-stage disease, including non-invasive, 
Stage 0 (in situ) and invasive, Stage I and II carcinomas.  Early stage breast cancers 
exhibit overall 5-year survival rates of 99% (Siegel et al., 2017).  
For most women with unilateral early stage breast cancer, decision making among 
surgical treatment options for the affected breast involves a choice between breast-
conserving surgery and mastectomy. With the addition of radiation therapy post-breast 
conserving surgery, either choice confers equivalent survival according to stage of 
disease (Early Breast Cancer Trialists' Group, 2011; Wong et al., 2017). Consideration is 
also given to management of the unaffected, contralateral breast.  In an average-risk 
population (i.e. those without inherited genetic predisposition or history of breast 
radiation exposure), risk of a contralateral breast cancer is low overall but increased as 
compared to women with no history of breast cancer. The annual increased risk estimate 
is in the range of 0.1-0.6% and 0.7-1.8% for women with ductal carcinoma in situ and 
invasive carcinoma respectively (Boughey et al., 2016; Early Breast Cancer Trialists' 
Group, 2011; Gao, Fisher, & Emami, 2003; Mamtani & Morrow, 2017; Quan, Pommier, 
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& Pommier, 2008; Tuttle et al., 2009)  Options for managing risk of a contralateral breast 
cancer include a schedule of screening and early detection measures such as breast 
imaging, chemoprevention with endocrine therapy agents, or contralateral prophylactic 
mastectomy.  In recent years, a significant trend in choosing contralateral prophylactic 
mastectomy has been identified in women with ductal carcinoma in situ and invasive, 
unilateral, early stage breast cancer (Jones et al., 2009; Pesce, Liederbach, Czechura, 
Winchester, & Yao, 2014; Tuttle, Habermann, Grund, Morris, & Virnig, 2007; Tuttle et 
al., 2009). The use of contralateral prophylactic mastectomy is an aggressive approach 
from the perspective of the medical community, involving removal of a presumptively 
normal organ for reduction of a seemingly low risk and without sufficient evidence of a 
survival advantage.  
1.2. Predictors of Surgical Choice 
The breast cancer surgical decision-making process for a woman with early stage, 
unilateral breast cancer is complex. The decision involves consideration of potential 
benefits and harms with each option, as well as decisions about future surveillance and 
risk. Options vary in regard to outcome, procedure, extent of surgery and recommended 
follow-up. Decisions are preceded by recommendations from health care practitioners 
from both disease and cosmetic perspective, opinions of family and significant others, 
and personal choice including the influence of cognitive and affective factors. Ultimately, 
the decision becomes one of personal preference in a decision-making process which is 
poorly understood.  
To date, most research into surgical decision making has been retrospective in 
nature, using demographic and clinic information collected in large databases to evaluate 
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predictors of surgical decision making.  Factors such as age, ethnicity, and level of 
education are examples of analysed variables as are clinical features such as tumor size 
and receptor status. There is some evidence to suggest that distress, anxiety, uncertainty, 
quality of life or worry about recurrence may be associated with surgical preference 
(Goel, Sawka, Thiel, Gort, & O'Connor, 2001; Graves et al., 2007; Hawley et al., 2014; 
Pedersen, Sawatzky, & Hack, 2010).  There is a prevalent assumption in the more recent 
medical literature suggesting women choosing mastectomy with CPM are not well-
informed about true local recurrence risk, contralateral breast cancer risk and survival 
outcomes. Their surgical choice is described as an overestimation of risk and 
misunderstanding about any survival advantage from that choice (Moffat & Yakoub, 
2016). The medical community is called upon to develop research initiatives, decision 
aids and supportive resources to assist women in this shared decision-making process 
(Burke, Portschy, & Tuttle, 2015; Rosenberg et al., 2013).  
1.3. Decision-Making 
Regarding medical decision-making in general, a theory-practice gap has been 
identified (Reyna, 2008).  Decision aid and support interventions tested in practice are 
not consistently based in identified theory, including many of the interventions which 
have been the subject of randomized controlled trials (Durand, Stiel, Boivin, & Elwyn, 
2008) . When applied, theoretical frameworks are often designed for normative decision-
making and are primarily focused on the cognitive domain.  The affective domain and 
individual characteristics in decision-making are often absent in theoretical frameworks 
in this subject area (Durand et al., 2008; Elwyn, Stiel, Durand, & Boivin, 2011; Pierce, 
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1993).  Research in the field is needed in order to inform the development of support and 
counseling resources.  
1.4. Summary of Subsequent Chapters 
Chapter Two is a report on the psychometric properties of the Anxiety Subscale 
of the Depression Anxiety Stress Scale in women undergoing a diagnostic mammogram.  
It is a secondary analysis of existing data from a prospective study.  Reliability and 
validity of the Depression Anxiety Stress Scale anxiety subscale was tested in 2672 
women who had been recalled for false-positive mammograms. Internal consistency 
testing included Cronbach coefficient alpha and the split-half technique to determine 
reliability.  Construct validity was assessed and factor analysis was conducted. The 
results of this analysis support the use of the DASS anxiety subscale as a reliable and 
valid measure of anxiety among women undergoing a diagnostic mammogram.   
Chapter Three is a critical review of decisional conflict measures.  The purpose of 
the analysis is to evaluate available decisional conflict scales for potential utilization at 
the time of surgical decision making among women with early stage breast cancer.  
Measurement of decisional conflict may promote the opportunity for high-quality 
surgical decision making. Decisional conflict scales may also be utilized for research 
with this population and in this setting. A review of the decisional conflict scale literature 
was undertaken.  Two scales were identified:  the Decisional Conflict Scale and the Sure 
of myself, Understand information, Risk-benefit ratio, Encouragement (SURE) screening 
test. Psychometric properties of each scale were researched and summarized.  The 16 
item Decisional Conflict Scale is the standard, most widely accepted and tested 
decisional conflict scale.  The four item SURE scale is shorter and easier to use in a 
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clinical setting.  This analysis supported the use of decisional conflict scales with women 
making surgical treatment decisions for breast cancer.  
 Chapter Four presents a prospective, exploratory, cross-sectional, mixed-methods 
study examining factors influencing preference for surgical choice among women with 
early stage breast cancer. Women were eligible to participate if they were newly 
diagnosed with unilateral, early stage breast cancer (defined as Stage 0, I or II) and if they 
were eligible to choose between the surgical options of breast conserving surgery or 
mastectomy with or without contralateral prophylactic mastectomy.  Analysis was limited 
to those women who chose either breast conserving surgery or mastectomy with 
contralateral prophylactic mastectomy; women choosing unilateral mastectomy were 
excluded from analysis. A total of 78 women were included in this analysis, 47 in the 
breast conserving surgery group and 31 in the bilateral mastectomy group. Differences in 
demographic, diagnostic, clinical, cognitive and affective variables were tested between 
the groups. Information sources were assessed by participant self-report. This study 
demonstrated differences between the two groups. Women who chose mastectomy with 
contralateral prophylactic mastectomy were younger, more likely to work full or part-
time, had larger tumors, participated in preoperative genetic counselling, had higher 
anxiety and breast cancer-specific distress.   Women who chose breast conserving 
surgery had higher decisional conflict.  Information sources were similar between the two 
groups but there were differences between the groups in the information source identified 
as the most influential.    
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CHAPTER TWO: 
Psychometric Evaluation of the Anxiety Subscale of the Depression Anxiety Stress 
Scale (DASS) in Women Recalled for False-Positive Mammograms 
2.1. Background 
Among women in the United States, breast cancer is the most common cancer and 
the second leading cause of cancer-related mortality.  Over 252,710 new cases of 
invasive breast cancers and 40,610 deaths due to breast cancer were expected in 2017 
(Siegel et al., 2017).  Breast cancer screening using mammography has significantly 
altered the diagnosis and prognosis of breast cancer, allowing for diagnosis in earlier 
stages when cancers are small and may be non-invasive (American Cancer Society, 2013; 
Smith, Duffy, & Tabar, 2012).  The five year survival rate for these localized, early-stage 
breast cancers is 99%, as compared to a five year survival rate of 85% for regional, and 
26% for metastatic disease (Siegel et al., 2017) . 
Cancer screening examinations including mammography are conducted on a 
healthy population of at-risk individuals. As is the case with any screening activity, 
potential benefits of screening a well population must be balanced against any potential 
harms of the examination.  Across all age groups, breast cancer screening with 
mammography exhibits 86.9% sensitivity and 88.9% specificity.  Sensitivity is highest 
(88.5%) in older women with less dense breast tissue and lowest (73.4%) in women 
between the ages of 40 and 44 (Breast Cancer Surveillance Consortium).  An abnormal 
screening exam results in follow-up or recall to a diagnostic phase consisting of 
additional and focused mammography imaging which may include ultrasound, biopsy 
and the use of other specific imaging technologies.  In the United States, the average 
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recall rate from screening mammography is 9.6%, ranging from 16.3% in women under 
40 to 6.9% in women over 80.  The  majority of women recalled for diagnostic 
mammograms will not have cancer, resulting in what is referred to as a false positive 
recall (Breast Cancer Surveillance Consortium). One of the potential harms of false 
positive recall is anxiety.   
Heightened anxiety in women recalled for false positive mammograms has been 
reported. The prevalence and severity of anxiety varies and is difficult to predict.  
Research has been conducted using different measures and methods (Nelson et al., 2016). 
In women with heightened anxiety, when contrasted with their baseline status or 
compared to women who were not recalled from screening exams, short-term anxiety has 
been found to be increased, with declining anxiety levels after negative results were 
communicated (Brewer, Salz, & Lillie, 2007; Ekeberg, Skjauff, & Karesen, 2001; Nelson 
et al., 2016; Schou Bredal, Karesen, Skaane, Engelstad, & Ekeberg, 2013). Long-term 
anxiety may persist in some women for weeks, months and years after a false positive 
mammogram (Bolejko, Hagell, Wann-Hansson, & Zackrisson, 2015; Brett & Austoker, 
2001; Brodersen & Siersma, 2013; Gotzsche & Jorgensen, 2013; Hafslund, Espehaug, & 
Nortvedt, 2012; Nelson et al., 2016).  Recognition of subsets of women with elevated 
anxiety in this population is recognized. Possible rationale may include the existence of 
baseline or state anxiety as well as the combined effects of conditions such as depression, 
decreased quality of life and diminished sense of well-being. Some women undergo more 
imaging and procedures during this phase than others and anxiety levels may differ 
accordingly. In addition, interventions on the part of healthcare providers such as 
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communication, education, counselling and support may have an effect (Bolejko et al., 
2015; Nelson et al., 2016).   
Measurement of anxiety in this population is inconsistent in method.  Single 
question items, visual analog/numeric rating scales and standardized anxiety scales and 
subscales such as the State Trait Anxiety Inventory, Consequences of Screening in Breast 
Cancer, Hospital Anxiety and Depression Scale, Impact of Events Scale, General Health 
Questionnaire, and the Psychosocial Consequences Questionnaire  have been used to 
measure anxiety (Brett, Bankhead, Henderson, Watson, & Austoker, 2005; Brewer et al., 
2007; Montgomery & McCrone, 2010; Nelson et al., 2016; Watson, Henderson, Brett, 
Bankhead, & Austoker, 2005).  There is a wide variation in the timepoints at which 
anxiety has been assessed including the time of recall and in the days, weeks, months and 
years after a false-positive exam (Brett et al., 2005; Brewer et al., 2007; Brodersen & 
Siersma, 2013; Gotzsche & Jorgensen, 2013; Nelson et al., 2016). 
Despite evidence of anxiety among women recalled for false positive 
mammograms, no consistent method or practice standard for measurement exists.  A 
scale that is reliable and valid, concise and implementable in practice for use in this 
population could give caregivers a means to effectively diagnose anxiety.  To date, use of 
the DASS anxiety subscale in this population has not been reported.  The purpose of this 
study is to evaluate the psychometric properties of the DASS anxiety subscale in the 
assessment of anxiety in women recalled for false positive mammograms.  The specific 
aims of this study were 1) to determine the reliability of the DASS anxiety subscale when 
used with women recalled for false-positive mammograms and 2) to evaluate construct 
and factorial validity of the DASS anxiety subscale.  Internal consistency testing included 
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Cronbach coefficient alpha and the split-half technique to determine reliability.  
Construct validity was assessed using hypothesis testing. Factorial validity was examined 
through factor analysis. The hypothesis tested was that of a negative correlation between 
psychological well-being and anxiety (Winefield, Gill, Taylor, & Pikington, 2012). 
2.2. Methods 
2.2.1 Study design. 
 A secondary analysis of data from a descriptive, explanatory study examining the 
psychological well-being of women undergoing diagnostic mammograms was conducted.  
Subjects who were subsequently diagnosed with cancer were excluded from this analysis 
in order to limit the sample to women recalled for a false-positive mammogram.   
2.2.2 Samples and setting. 
The original study was conducted in a breast imaging department of a 391-bed 
Magnet®-designated hospital in the south eastern region of the United States.  For all 
participants in the study, data were collected during the diagnostic mammogram visit in 
the healthcare setting and before results of the exam were known. Women were eligible 
to participate if they were age 18 or older, able to read, write and understand English, 
undergoing a diagnostic mammogram and if they provided consent to participate.  
Women who had a prior personal history of cancer or were unable to complete the 
questionnaires without assistance were excluded.   
The convenience sample of women included 2973 total participants, 2928 of 
whom were healthy and 45 of whom were subsequently diagnosed with breast cancer.  
After removing those with breast cancer (n=45) and those with missing data, a total of 
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2672 women recalled for a false positive mammogram remained and were included in 
this analysis. 
2.2.3 Procedure. 
This study was approved by the study site’s Institutional Review Board.  Potential 
participants included all women undergoing diagnostic mammograms during the study 
period. A research assistant introduced the study and invited women to participate as they 
were waiting to be called for their diagnostic mammogram.  Those who agreed to 
participate, met criteria for inclusion and completed informed consent were enrolled in 
the study. Women were provided a study packet of printed questionnaires to complete 
and return before leaving the breast imaging department.  Completion of the study packet 
took approximately 20 minutes.   
2.3. Variables and Measures 
2.3.1 Demographics. 
Demographic data were collected with a self-report questionnaire.  Participants 
were asked to report variables including age, race/ethnicity, marital status, level of 
education, employment status, income level, primary wage earner status (yes/no), 
religious affiliation and family history of cancer (yes/no/adopted).   
2.3.2 Anxiety Subscale of the Depression Anxiety Stress Scale. 
Anxiety was assessed using the Depression Anxiety Stress Scale (DASS).  The 
DASS consists of 42 items. Respondents are asked to identify and answer on a four-point 
scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much or most of 
the time). Participants are asked to include experiences from the preceding week when 
responding.  Fourteen items of the DASS pertain to depression, 14 to anxiety and 14 to 
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stress and items for each of these three subscales are interspersed among the other 
subscale items. Higher scores represent higher depression, anxiety and stress on the 
representative subscale.   
Prior studies with the DASS have established good reliability and validity in both 
clinical and non-clinical populations.  Cronbach alpha in these studies for the overall 
DASS have ranged from 0.84-0.897 (Crawford & Henry, 2003; Lovibond & Lovibond, 
1995).  Cronbach alpha for the DASS anxiety subscale likewise indicates good reliability, 
ranging from 0.897- 0.92 (Antony, 1998; Brown, Chorpita, Korotitsch, & Barlow, 1997; 
Crawford & Henry, 2003; Cunningham, Brown, Brooks, & Page, 2013; Nieuwenhuijsen, 
de Boer, Verbeek, Blonk, & van Dijk, 2003).  Validity of the DASS anxiety subscale has 
been assessed using several methods.  In a sample of over 700 psychology students, 
concurrent validity was measured against the Beck Anxiety Inventory.  The two scales 
were highly correlated (r = 0.81) (Lovibond & Lovibond, 1995).  Convergent validity 
between the anxiety subscale of the DASS and the anxiety subscale of  the Hospital 
Anxiety and Depression Scale and the Personal Disturbance Scale, Beck Anxiety 
Inventory and the State Trait Anxiety Inventory  were significantly correlated across 
studies with correlations ranging from r = 0.67 -  0.84. These findings indicate that the 
DASS anxiety subscale conceptually measures anxiety similarly to other established 
measures (Antony, 1998; Crawford & Henry, 2003; Nieuwenhuijsen et al., 2003).  
Confirmatory factor analysis of the three subscales of the overall DASS has been 
replicated with both community and clinical samples. No previous use of the DASS 
anxiety subscale in women recalled for false-positive mammograms was found.   
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2.3.3 Ryff Scale of Psychological Well-Being. 
Psychological well-being was assessed using the Ryff Scale of Psychological 
Well-Being (SPWB).  Six dimensions of psychological well-being are measured with 
separate subscales and include: autonomy, purpose in life, positive relations with others, 
personal growth, environmental mastery, and self-acceptance.  The total scale includes 84 
items.  Each subscale consists of 14 items to which participants are asked to rate 
responses on a six-point Likert scale ranging from (1) strongly disagree to (6) strongly 
agree.  Higher scores indicate higher well-being. Internal consistency coefficients for the 
subscales have tested between .86 and .93.  Test retest of all subscales are in the range of 
.81 - .88 (C. D. Ryff & Keyes, 1995; C.D. Ryff, 1989).  The Ryff SPWB was used for 
validity hypothesis testing in this analysis. 
2.4. Methods for Testing Psychometric Properties of the DASS Anxiety Subscale 
All data analysis was performed using IBM® SPSS® Statistics (version 21).  The 
level of significance was set at a p value of .05 or less.  Descriptive statistics including 
means, standard deviations and frequency percentages were used to characterize the 
sample demographics. 
2.4.1 Reliability. 
 Cronbach coefficient alpha, a measure of internal consistency among anxiety 
subscale items, was used to determine reliability.  A Cronbach coefficient alpha greater 
than .70 was considered acceptable.  Inter-item correlations and item-total correlations 
were used to test the characteristics of the anxiety subscale items and to test their 
relationship to each other.   Inter-item correlations between .20 and .80 were considered 
acceptable.  Reliability was also tested using the split-half technique, which yields a 
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Spearman-Brown coefficient greater than .70. A coefficient greater than 0.70 was 
considered acceptable. 
2.4.2 Construct and Factorial Validity. 
Construct and factorial validity were assessed using hypothesis testing and factor 
analysis. The hypothesis tested was that of a negative correlation between psychological 
well-being and anxiety.  To measure the strength of the hypothesized relationship 
between anxiety and SPWB, scores were analyzed using the Pearson product-moment 
correlation.   
Confirmatory factor analysis of the DASS anxiety subscale was conducted.  
Suitability for factor analysis was confirmed by evaluating the basic requirements of a 
minimum number of at least three response options, minimum sample size (at least 100), 
and ten cases per item.  Bartlett’s test of sphericity was used to evaluate the correlation 
matrix.  Matrix sample adequacy was evaluated using the Keiser-Meyer-Olkin (KMO) 
test.  KMO criterion values greater than .60 were considered adequate.  Principal 
component analysis extraction with varimax rotation was performed; eigenvalues of 
greater than one were retained and a scree test was used to plot the eigenvalues of the 
factors.  Loadings greater than .40 were used to identify items associated with a factor.  
Crossloaded factors were defined as those loading similarly on more than one factor with 
a difference of less than .20. 
2.5. Results 
2.5.1 Sample Characteristics. 
Table 2.1 shows the characteristics of the women recalled for a false positive 
mammogram (n = 2672).  All demographic variables were self-reported and in some 
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cases, were self-defined.  For example the question asking about main wage earner status 
asked “are you the main wage earner in your household?” and participants answered 
“yes” or “no”. The sample was predominately Caucasian (92%), married/partnered 
(71%), had completed college or graduate school (70%), was employed full- or part-time 
(66%) and the majority reported an income level greater than $40,000 per year (72%).  
Most participants did not identify themselves as the primary wage earner (62%).  Over 
90% identified themselves as having a religious affiliation and 69% had a family history 
of cancer (< 1% were adopted or did not know).  The mean age of women in this sample 
was 50 (± 11).  
The mean anxiety score was 4.3 (± 6, range 0-42) which is consistent with mean 
normative DASS anxiety scores for women (Lovibond & Lovibond, 1995; 
Nieuwenhuijsen et al., 2003).  The median anxiety score was two.  Anxiety scores ranged 
from zero to forty-two.  Six hundred fifteen women had an anxiety score of zero 
accounting for 23% of the sample.  Two women had a score of 42 (Table 2.2). 
2.5.2 Reliability.   
 Cronbach alpha for the DASS anxiety subscale was .895, indicating good internal 
consistency among the items.  The overall mean for the anxiety subscale item correlations 
in this sample was .396, indicating good interrelatedness among the items.  Table 2.3 
displays inter-item correlations, item-total correlations, means and standard deviations.  
Inter-item correlations ranged from .217 - .633 indicating good correlations of each item 
with the total score.  Item specific means ranged from a low of .146 ± .447 to a high of 
.634 ± .894. The standard deviation is higher than the mean for all items which is 
indicative of the low overall anxiety scores in this sample.   
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Deletion of any one item from the anxiety subscale would maintain the Cronbach 
alpha between .88 - .90, therefore no indication of poor items in this subscale was found 
(Table 2.4).  The Spearman-Brown Coefficient for split-half reliability testing was 
acceptable at .891 
2.5.3 Construct Validity. 
2.5.3.1 Hypothesis Testing. 
To test the hypothesis of a negative correlation between DASS anxiety subscale 
scores and SPWB scores, the Pearson product-moment correlation was calculated.  A 
significant negative correlation was found between anxiety and psychological well-being 
(r = -.496, p < .01), resulting in a rejection of the null hypothesis. 
2.5.3.2 Principal Component Analysis. 
The 14 item DASS anxiety subscale was assessed with principal component 
analysis (PCA).  Before analysis, the suitability of the DASS anxiety subscale for PCA 
was assessed.  The subscale met the requirements for number of response criteria.  
Requirements for sample size and number of cases per item were also met.  Bartlett’s test 
of sphericity was significant (p < .01) therefore the null hypothesis that the correlation 
matrix is an identity matrix is rejected.  The matrix sample adequacy is considered 
adequate (KMO = .946) and the determination of the correlation matrix was adequate 
(.004). 
 The minimum number of factors represented in the subscale was evaluated.  Two 
factors were retained and rotated using varimax rotation (Table 2.5) based on eigenvalues 
greater than one, scree plot and explanation of total variance.  The two factors split 
between emotional/psychological manifestations of anxiety and physical manifestations 
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of anxiety.  Those items in the emotional/psychological dimension included words such 
as panic, terror, feeling scared, fear and anxiety.  Those items in the physical dimension 
included DASS items referring to breathing difficulty, dry mouth, faintness, shakiness, 
difficulty swallowing, heart rate or rhythm and perspiration.  DASS item 41 “I found it 
difficult to work up the initiative to do things” met criteria for retention and crossloading 
(.509 for the first factor and .560 for the second factor). The item was retained to the 
factor with the highest loading.  A cutpoint of .40 was used to define factor loading. 
2.6. Discussion 
 Reliability and validity of the DASS anxiety subscale in women undergoing false 
positive recalls is supported by this analysis. Measures of internal consistency and 
correlation of items within the subscale confirmed reliability in this sample.  Construct 
validity was supported with hypothesis testing.  Factor analysis provided support for two 
factors.  The first factor includes six items which measure emotional/psychological 
dimensions of anxiety such as panic, terror and fear.  The second factor includes eight 
items that measure action and physical symptoms of anxiety such as sweating, rapid or 
irregular heart rate and dry mouth. One item met crossloading criteria (i.e. loading 
similarly on more than one factor with a difference of less than .20) but fell more closely 
within the second factor items in the physical dimension and was retained to that factor.  
Although anxiety has been previously reported to be a negative effect of false 
positive mammograms, the mean anxiety score of 4.3 for this sample falls within the 
normal range.  In this study, however, 23% of women had an anxiety score of zero. Five 
percent reported anxiety levels over 15.  Levels over 15 are considered high levels of 
anxiety as measured by the DASS (Lovibond & Lovibond, 1995).  This finding is 
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consistent with previous reports in which a subset of women exhibit heightened anxiety 
in this setting (Gotzsche & Jorgensen, 2013).  It is possible that this subset of women 
exhibited baseline heightened anxiety or trait anxiety.  In this secondary analysis, 
however, examination is limited to the data collected and examination of those 
considerations is not possible. It is also possible that this sample is not representative of 
the population.  It was a convenience sample and subjects volunteered to be part of the 
study.  It is possible that the sample is biased toward women with lower anxiety who 
volunteered to participate and absent those with heightened anxiety who refused to 
participate. 
 In the original study, completion of the entire packet of questionnaires took less 
than 20 minutes.  The complete DASS was just one part of that packet.  From a feasibility 
perspective, use of the DASS anxiety subscale to assess anxiety would be possible in a 
clinical setting. It would not take much time to complete and as demonstrated by the 
original study, is easy to distribute as women wait for their diagnostic mammograms. The 
subscale is concise, consisting of only 14 items.  Currently, no consistent method or 
practice standard for measurement of anxiety in this population of women exists but 
implementation of an assessment tool could improve anxiety diagnosis, intervention and 
overall quality of care in this setting.   
2.7. Limitations 
Secondary data analyses are limited to analyzing data on the variables that were 
examined.  For example, another measure of anxiety, even breast screening –specific 
anxiety, may have provided meaningful information Variables were self-reported and 
may be subject to bias. The sample was homogenous in terms of income, education and 
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marital status. A sample drawn from a more heterogeneous population might have 
produced different results. This positive skew may be reflective of the lack of volunteers 
among women with heightened anxiety in this setting.   
2.8. Conclusions 
 The DASS anxiety subscale showed good reliability in women recalled for false 
positive mammograms and validity was supported by both hypothesis testing and factor 
analysis.  A 14-item subscale is concise and feasible for use in a clinical setting.  The 
potential benefits of breast cancer screening with mammography are evident in the 
increased survival and shift toward early stage diagnosis.  Potential harms, including 
anxiety, still need to be addressed.  Informed consent should ideally include accurate 
information about potential benefits and harms of screening but until anxiety is 
consistently measured and until the subsets of women with heightened anxiety are more 
fully described, full disclosure of this potential harm is not possible.  Consistent use of 
the DASS anxiety subscale in this setting is encouraged as is the replication of reliability 
and validity testing with its use in women recalled for false positive mammograms.  
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Table 2.1 
  
Characteristics of Women Recalled for False-Positive Mammograms  
 Demographic 
 
Total Sample 
 
(n = 2672) 
 
Age (years), mean (± SD)  50  ± 11 
 
Race/Ethnicity 
Caucasian 
Non-Caucasian 
2459 (92) 
  213   (8) 
 
Marital Status 
Married/Partnered 
Divorced/Separated/Single/ 
Widowed 
1891 (71) 
  781 (29) 
 
 
Education 
Elementary/High School 
College/Graduate School 
  800 (30) 
1872 (70) 
 
Employment 
Full- or Part-Time  
Other 
1763 (66) 
  909 (34) 
 
Income 
<20,000 
20,001 to 40,000 
40,001 to 80, 000 
>80,000 
  
 252   (9) 
 473 (18) 
 893  (33) 
1054 (39) 
 
Primary Wage Earner 
Yes 
No 
1011 (38) 
1661 (62)   
 
Religious Affiliation 
None 
Catholic/Protestant/Jewish/Muslim/Other 
     
  
251   (9) 
2421 (91) 
 
Family History of Cancer 
Yes 
No 
Adopted 
1833 (69) 
   820 (30) 
    19   (1) 
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Table 2.2 
 
DASS Anxiety Subscale Scores 
 
Total Sample 
(n = 2672) 
 
Mean (± SD) 
 
4.3 ± 6 
 
Median 
 
2 
 
 
Range 
 
0 – 42 
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Table 2.3   
DASS Anxiety Subscale Inter-item Correlations, Item-Total Correlations, Means and Standard Deviations  
 
Item Correlations 
 
 
 
DASS  
2 
 
 
DASS 
 4 
 
DASS 
 7 
 
DASS 
 9 
 
DASS 
15 
 
DASS 
19 
 
DASS 
20 
 
DASS  
23 
 
DASS 
25 
 
 
DASS 
28 
 
 
DASS 
30 
 
 
DASS 
36 
 
 
DASS 
40 
 
 
DASS 
41 
 
 
Item-Total 
Correlation 
 
Mean 
 
SD 
 
DASS 
2 
 
1.000              .399 .634 .894 
DASS
4 .306 1.000             .574 .315 .680 
DASS 
7 .298 .457 1.000            .650 .270 .626 
DASS 
9 .303 .379 .449 1.000           .629 .594 .827 
DASS
15 .276 .395 .501 .362 1.000          .566 .146 .447 
DASS
19 .259 .312 .384 .347 .327 1.000         .501 .298 .685 
DASS 
20 .217 .346 .433 .424 .376 .367 1.000        .625 .256 .592 
DASS
23 .302 .393 .387 .332 .371 .265 .338 1.000       .508 .148 .462 
DASS 
25 .265 .464 .413 .384 .390 .336 .400 .326 1.000      .572 .384 .708 
DASS 
28 .286 .464 .504 .571 .456 .395 .591 .379 .478 1.000     .752 .273 .656 
DASS
30 .217 .323 .322 .457 .306 .289 .451 .306 .336 .483 1.000    .556 .279 .623 
DASS
36 .220 .349 .442 .424 .370 .334 .568 .319 .366 .633 .426 1.000   .633 .202 .572 
DASS 
40 .267 .359 .440 .530 .341 .386 .493 .338 .386 .613 .536 .543 1.000  .671 .282 .637 
DASS 
41 .313 .440 .610 .452 .468 .378 .439 .383 .433 .575 .385 .509 .520 1.000 .685 .224 .599 
DASS Subscale Items: DASS 2 “I was aware of dryness of my mouth,” DASS 4 “I experienced breathing difficulty (eg. excessively rapid breathing, breathlessness in the absence of physical exertion,” DASS 7 “I had a feeling of 
shakiness (eg, legs going to give way,” DASS 9 “I found myself in situations that made me so anxious I was almost relieved when they ended,” DASS 15 “I had a feeling of faintness,” DASS 19 “I perspired noticeably (eg hands 
sweaty) in the absence of high temperatures or physical exertion,” DASS 20 “I felt scared without any good reason,” DASS 23 “I had difficulty swallowing,” DASS 25 “I was aware of the action of my heart in the absence of 
physical exertion (eg sense of heart rate increase, heart missing a beat),” DASS 28 I felt I was close to panic,” DASS 30 “I feared that I would be ‘thrown’ by some trivial but unfamiliar task,” DASS 36: “I fell terrified,”  DASS40 
“I was worried about situations in which I might panic and make a fool of myself,” DASS 41” I found it difficult to work up the initiative to do things” 
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Table 2.4 
 
DASS Anxiety Subscale: Cronbach Alpha by Deleted Items 
DASS Anxiety Subscale Item 
Cronbach 
alpha 
if Item 
Deleted 
DASS2  
I was aware of dryness of my mouth 
.900 
DASS4 
I experienced breathing difficulty (eg excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
.888 
DASS7 
I had a feeling of shakiness (eg legs going to give way) 
.885 
DASS9 
I found myself in situations that made me so anxious I was almost relieved 
when they ended 
.886 
DASS15 
I had a feeling of faintness 
.890 
DASS19 
I perspired noticeably (eg hands sweaty) in the absence of high temperatures 
or physical exertion 
.891 
DASS20 
I felt scared without any good reason 
.886 
DASS23 
I had difficulty swallowing 
.891 
DASS25 
I was aware of the action of my heart in the absence of physical exertion (eg 
sense of heart rate increase, heart missing a beat) 
.888 
DASS28 
I felt I was close to panic 
.880 
DASS30 
I feared that I would be “thrown” by some trivial but unfamiliar task 
.889 
DASS36 
I feel terrified 
.886 
DASS40 
I was worried about situations in which I might panic and make a fool of 
myself 
.884 
DASS41 
I found it difficult to work up the initiative to do things 
.884 
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Table 2.5 
 
Factor Analysis with Varimax Rotation of the DASS Anxiety Subscale (n = 2672) 
Item 
 
Factors 
  
DASS 40 
I was worried about situations in which I might panic and make a 
fool of myself 
.766 .247 
DASS 36 
I feel terrified 
.751 .227 
DASS 28 
I felt I was close to panic 
.747 .385 
DASS 20 
I felt scared without any good reason 
.720 .245 
DASS 30 
I feared that I would be “thrown” by some trivial but unfamiliar 
task 
.706 .151 
DASS 9 
I found myself in situations that made me so anxious I was almost 
relieved when they ended 
.608 .362 
DASS 4 
I experienced breathing difficulty (eg excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
.255 .675 
DASS 2 
I was aware of dryness of my mouth 
 .644 
DASS 15 
I had a feeling of faintness 
.282 .639 
DASS 7 
I had a feeling of shakiness (eg legs going to give way) 
.395 .639 
DASS 23 
I had difficulty swallowing 
.215 .618 
DASS 41 
I found it difficult to work up the initiative to do things 
.509 .560 
DASS 25 
I was aware of the action of my heart in the absence of physical 
exertion (eg sense of heart rate increase, heart missing a beat) 
.364 .555 
DASS 19 
I perspired noticeably (eg hands sweaty) in the absence of high 
temperatures or physical exertion 
.380 .427 
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CHAPTER THREE: 
Critical Review of Decisional Conflict Scales for Use during 
Breast Cancer Surgical Decision Making 
3.1. Introduction 
Decisional conflict is defined as a perceived state of uncertainty about a course of 
action (Legare et al., 2010; Annette M. O'Connor, 1995). It is more likely to occur when 
making choices that are serious, affect potential gains and losses, involve risk, require 
value trade-offs in the decision, and when regret, from either the choice taken or the 
choice rejected, and is a possibility (Koedoot et al., 2001; A.M. O'Connor, 1993). The 
surgery decision making process among women with early-stage breast cancer has the 
potential for decisional conflict.  
Decisional conflict is an indication of level of comfort with a decision (Annette M. 
O'Connor, 1995). Among women with early-stage breast cancer, surgical decisions are 
complex in and of themselves, but other factors may contribute to the complexity. The 
time from diagnosis to surgical consultation is short, often spanning only a few days 
resulting in a situation in which decisions are made quickly, possibly without sufficient 
consideration. Consultation time with providers can be limited. In addition, health 
literacy among women making these decisions may vary widely. Choices among 
decisions may carry significant risk and hidden meaning. In this setting, measurement of 
decisional conflict may facilitate communication between patients and healthcare 
providers about the level of comfort with the surgical decision (Kokufu, 2012). 
Opportunities for improvements in the decision making process may become apparent if 
decisional conflict is known (Legare et al., 2003).   
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Measurement of decisional conflict may also provide a method for evaluation of 
interventions in this setting. For example, research on the effect of decision aids, 
education or counseling sessions have included decisional conflict scales to evaluate the 
effect of the intervention (Kryworuchko, Stacey, Bennett, & Graham, 2008; Obeidat, 
Finnell, & Lally, 2011). The purpose of this critical review and analysis is to examine 
decisional conflict measurement in order to evaluate utilization of those scales during the 
time of surgical decision making among women with early-stage breast cancer from both 
a research and clinical perspective.    
3.2. Breast Cancer and Surgical Decisions 
Breast cancer is the most commonly diagnosed cancer and the second leading cause 
of cancer-related mortality among women in the United States. Over 252,710 new cases 
of breast cancer and 40,610 deaths due to breast cancer are expected to occur in 2017 
(Siegel et al., 2017).  At time of presentation, the majority of breast cancers are unilateral 
and localized. They are described as early-stage disease including Stage I, Stage II and 
the non-invasive Stage 0 tumors (Siegel et al., 2017). For women with unilateral, early-
stage breast cancer, surgical treatment options for the affected breast include either 
breast-conserving surgery (BCS) or mastectomy. Some women choose mastectomy with 
contralateral prophylactic mastectomy. Surgical choice in early-stage breast cancer is 
described as a preference-based decision that is not well understood (Mamtani & 
Morrow, 2017). 
Choosing among surgical options is a shared decision making process involving 
recommendations from health care providers from both a disease and cosmetic 
perspective. Opinions of family and significant others as well as personal choice 
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regarding the procedure are involved. Option-specific considerations of time, travel, 
comfort and desired outcome may also be included. The potential for decisional conflict 
is evident in this situation involving high-stakes choices which may impact risk of 
recurrence and chance of survival. Potential loss or significant physical alterations of one 
or both breasts, trade-offs in terms of quality of life and functioning due to treatment and 
future surveillance, and potential future regret for any of the choices which are made are 
also involved.   
3.3. Decisional Conflict and Measurement 
The identification of conflict as a component of decision making was described in the 
1970’s  in the conflict-theory model of decision making (Janis & Mann, 1976). In this 
model, stress is recognized as a component of decision making, an influence on the 
coping pattern exhibited throughout the decision making process and ultimately as an 
alterant of the perceived quality of the decision. Stress from conflict may contribute to 
failure in achieving high-quality decisions (Mann, Burnett, Radford, & Ford, 1997). High 
quality decisions are thought to increase adherence and limit post decisional regret 
(Balneaves & Long, 1999). More recent research into decision making reported decisions 
as a review of a “personal balance account… [which] comprises the physical and 
emotional gains patients hope to get minus the risks and other negative aspects.”(Noone, 
2002) It is the choice between options that underlie conflict and stress. In the early 
1990’s, O’Connor developed the Decisional Conflict Scale (DCS) to measure personal 
perceptions of uncertainty in the decision, factors that add to perceptions of uncertainty 
which are potentially modified (such as feeling unsupported in the decision) and the 
effectiveness of the decision (A.M. O'Connor, 1993).  
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Psychometric properties of the DCS were published in 1995 (Annette M. O'Connor, 
1995). Subsequently, an adapted and shorter decisional conflict scale known as the Sure 
of myself, Understand information, Risk-benefit ratio, Encouragement (SURE) screening 
test was derived from the DCS (Legare et al., 2010). The DCS and SURE were chosen 
for review and analysis. Characteristics of the scales are outlined in Table 3.1.  
3.4. Analysis of Decisional Conflict Measures 
3.4.1 Decisional Conflict Scale. 
The original DCS consists of 16 total items in statement format. Responses are made 
using a five point Likert scale ranging from 0 (strongly agree) to 4 (strongly disagree). 
Total scores are summed, divided by 16 and then multiplied by 25, resulting in a 
decisional conflict score ranging from 0 to 100. Low scores represent low decisional 
conflict and high scores represent high decisional conflict. Scores above 37.5 are 
associated with feeling unsure about the decision and with decisional delay (Annette M. 
O'Connor, 1995). The DCS is formatted at an 8th grade reading level and takes 10 – 20 
minutes to complete (Legare et al., 2010; A.M. O'Connor, 1993; Annette M. O'Connor, 
1995).   
The 16-item DCS is made up of the following five subscales:  uncertainty, informed, 
values clarity, support, and effective decision. Three items constitute each subscale 
except for the effective decision subscale which includes four items. The effective 
decision subscale is intended for use only after a decision has been made. Other subscales 
may be used in the process of decision making and/or after a decision has been made. 
High subscale scores represent high decisional conflict in that specific area. No specific 
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score is identified as indicative of high verses low decisional conflict within a subscale 
(A.M. O'Connor, 1993). 
A summary of DCS and subscale reliability and validity is provided in Table 3.2.  
Various formats, translations and modifications of formats have been tested and reported. 
Coefficient alpha for the total DCS has been acceptable (α > 0.70 in all reports) 
(Katapodi, Munro, Pierce, & Williams, 2011; Linder et al., 2011; Mancini, Santin, 
Chabal, & Julian-Reynier, 2006; A.M. O'Connor, 1993; Annette M. O'Connor, 1995). 
Psychometric testing of DCS English and French versions, when the scale was post-
exploratory, reported coefficient alphas > 0.90 which may suggest item redundancy. In 
both reports, factor analysis resulted in an alternate factor model (Katapodi et al., 2011; 
Mancini et al., 2006). Lam, et al. (2012), tested a Chinese version of the DCS and found 
two cross-loading items, one from the uncertainty subscale “Are you clear about the best 
choice for you?” and one from the effective decision subscale, ‘Do you feel you have 
made an informed choice?” Both were removed. The coefficient alpha tested on the 14-
item scale = 0.81.  
Subscale reliability testing is difficult to summarize owing to the modifications made 
to subscales across reports (see Table 3.2). The original three subscales are reported by 
O’Connor (1995) and Koedoot (2001). Modified subscales are reported by Katapodi 
(2011) and Lam (2012). The current five subscales for the 16-item DCS are reported by 
Mancini (2006).  Linder (2011) tested the 10-item DCS and reported the standard four 
subscales of informed, values clarity, support and uncertainty (Linder et al., 2011). The 
support subscale resulted in coefficient alpha <0.70 in three reports, two of which tested  
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the standard DCS subscales (Linder et al., 2011; Mancini et al., 2006) and one which 
tested a modified support subscale (Lam et al., 2012).  
Tests of validity have included the known-groups approach in which groups within 
samples were compared based on whether a decision had been made or not. Hypotheses 
testing was also reported (Table 3.2). In each test of validity, the DCS performed well. 
Factor analysis has been conducted without confirmation of the current scale’s five-factor 
model. Mancini (2006) and Koedoot (2001) report a four-factor model, Katapodi (2011) 
and Lam (2012) report a three-factor model. Regarding the low-literacy, 10-item version 
of the DCS, a four-factor model was confirmed (Linder et al., 2011). 
The groups chosen for reliability and validity testing were dissimilar as was the 
gravity of the decision being made. The samples included healthy populations of students 
and healthcare workers considering influenza vaccination and healthy women 
considering breast cancer screening as well as women newly diagnosed with breast 
cancer considering treatment and those with metastatic cancer considering palliative 
chemotherapy. Context of decision-making may warrant consideration in evaluating DCS 
and subscales psychometrics as noted by Mancini (2006) with low level of conflict 
making it more difficult to distinguish between factors when tested (Mancini et al., 2006).  
English, French, Dutch and Chinese versions of the DCS were tested with the French, 
Dutch and Chinese versions translated for testing. It is possible for translations to account 
for some differences in psychometric testing. The “wording” of items is specifically 
noted as a potential for differences in factorial validity in the Dutch translation (Koedoot 
et al., 2001).   
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3.4.2 SURE Screening Test. 
The Sure of myself, Understand information, Risk-benefit ratio, Encouragement 
(SURE) screening test was developed to be a shorter, less time intensive decisional 
conflict measure as compared to the DCS. In developing a more concise measure, the 
investigators hoped to provide a measure that would be clinically useful in health care 
settings, especially as an efficient screening tool for decisional conflict (Legare et al., 
2010). The scale is based on the DCS and the core concepts of the Ottawa Decision 
Support Framework including: feeling uncertain, feeling informed, feeling clear about 
values and feeling supported in decision making (Legare et al., 2010; Legare, O'Connor, 
Graham, Wells, & Tremblay, 2006). SURE scales were developed concurrently in both 
French and English and were framed in such a way as to form the acronym SURE in both 
languages. The SURE scale is a 4-item test in which all statements are positively worded. 
Respondents answers “yes,” or “no” to each item. A score of 1 is assigned to “yes” 
answers and a score of 0 is assigned to “no” answers. Scores are summed and range from 
0 (high decisional conflict) to 4 (no decisional conflict). A score of ≤ 3 is indicative of 
decisional conflict (Ferron Parayre, Labrecque, Rousseau, Turcotte, & Légaré, 2014; 
A.M. O'Connor, 1993).   
Results of reliability and validity testing for the SURE test were first published in 
2010. The measure was tested in two groups of patients actively involved in making a 
healthcare decision. The first group was made up of 123 French speaking, pregnant 
women who were in the process of making decisions about participation in prenatal 
Downs Syndrome screening. The second group was made up of 1474 English speaking 
patients facing various health care decisions for chronic conditions and cancers. Fifteen 
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percent of the French speaking, and 33% of the English speaking sample, had scores 
indicative of decisional conflict (i.e. ≤ 3) (Legare et al., 2010). 
Reliability of the SURE test may be described as moderate with Cronbach alpha of 
0.54 in the French-speaking pregnant women and 0.65 in the English-speaking patients. 
Removing the Encouragement item (Do you have enough support and advice to make the 
choice?), resulted in an increased Cronbach alpha to 0.61 in the French-speaking 
pregnant women group. Item-to-total Pearson correlation coefficients ranged from 0.32 to 
0.59 with the exception of the Encouragement item which showed a very minimal 
positive correlation of 0.07. Item-to-item correlations were positive, ranging from 0.46 to 
0.71 with the exception of the Encouragement item which was negatively correlated with 
both the Knowledge and Value items (Legare et al., 2010).   
Several tests of SURE validity were completed. Before testing began, content validity 
of the SURE test was “field-tested” by what Legare et al (2010) describe as experts and 
graduate students taking courses in decisional support. Unfortunately, no discussion of 
how the experts were recruited or exclusion/inclusion criteria was provided. Convergent 
validity was assessed in the group of 123 women who completed both the DCS and 
SURE. SURE scores were negatively correlated with the DCS score (Pearson r = -0.46, p 
< 0.0001). The hypothesis that the SURE test scores would discriminate between patients 
who had made a decision and those who had not was tested. Patients who had not made 
decisions about treatment had significantly lower scores than those who had made a 
decision (p < .0001). A factor analysis in the scores from the group of pregnant women 
was conducted, finding two factors accounting for 72% of the variance. All items except  
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the Encouragement item loaded under one factor (Legare et al., 2010). Overall, the SURE 
test was acceptably valid and moderately reliable in the initial validation work.   
A secondary data analysis of psychometric properties of the SURE test was published 
in 2013. Six hundred fifty four primary care patients who participated in a randomized 
trial assessing an intervention on shared decision making completed both the DCS and 
SURE test. DCS and SURE scores were significantly correlated (Spearman’s p = -0.45, p 
<0.0001) (Ferron Parayre et al., 2014). 
3.5. Strengths and Limitations 
A particular strength of decisional conflict scales can be found in the theoretical and 
empirical background of the construct. The construct of decisional conflict is well 
developed and researched and has been an accepted nursing diagnosis for over two 
decades. The behavioural and minor manifestations of decisional conflict are identified as 
consequences and interventions (A.M. O'Connor, 1993). According to O’Connor (1995), 
the conceptual framework for the construct of decisional conflict served as the basis for 
DCS development (Annette M. O'Connor, 1995). The SURE test was based on the DCS 
and developed from the Ottawa Decision Support Framework of which decisional 
conflict is a part (Legare et al., 2010). 
The DCS scales are reported as feasible and understandable. The scale with the 
greatest numbers of items is the DCS (16 items) and may take 10 – 20 minutes to 
complete. The SURE test has only 4 items and is a clinical-use version of the DCS.   
Testing of the scales indicates moderate to acceptable reliability with some 
exceptions for subscale items. Overall, subscale and total DCS reliability testing showed 
acceptable internal consistency. Moderate reliability was found with the SURE test 
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(Cronbach alpha of 0.54 - 0.65 in two groups). Reliability was increased with the removal 
of one item. In the current SURE test, all four items continue to be included (A.M. 
O'Connor, 1993). More testing with larger samples in various populations has been 
encouraged by the investigators (Legare et al., 2010). Factor analysis should be addressed 
in future studies (Legare et al., 2010). 
A limitation consistent to decisional conflict scales is the lack of discussion regarding 
scale development; O’Connor (1995) describes item and subscale development to be 
based on the construct of decisional support. Unfortunately, very little information is 
provided about the development, testing and revision of items, subscales and total scale 
(Annette M. O'Connor, 1995). The actual development of the particular items is not 
described in detail. Cut-off scores or scores of significance are also not well described in 
the literature. A score of 37.5 is reported to have meaning for the DCS scale yet an 
associated reference is not provided (A.M. O'Connor, 1993).   
3.6. Recommendations for New Directions in Measurement of Decisional Conflict 
In regard to the psychometric properties of the decisional conflict scales reviewed and 
analyzed in this manuscript, some questions remain. For the 16-item DCS, a three-, four-, 
and five-dimension structure has been reported in different populations and with different 
translations of the instrument. The support subscale in particular, shows variation in 
reliability and factor analyses. Perhaps the targeted population for testing is an important 
factor.  For example, decisional conflict may be present in higher levels or may be related 
to different aspects of the construct and therefore exhibit different dimensions, depending 
on the nature of the population, decision being made, or the wording used for the 
instrument. It seems probable that decisional conflict exhibited by someone making a 
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decision about immunization could be different from decisional conflict exhibited by 
someone facing a life-threatening illness and surgery. Future research should be focused 
on the nature of decisional conflict in different populations and the meaning and 
usefulness of all subscales across all populations. 
In the population of women with early-stage breast cancer making surgical decisions, 
decisional conflict should be a focus of further study. Several retrospective reviews have 
investigated patient and practitioner predictors of surgical decision making. To date, very 
few prospective studies of the decision-making process have been completed. Most 
research in this setting which includes measurement of decisional conflict is focused on 
the use of decision aids or interventions. The differences in decisional conflict scores are 
assessed pre- and post-intervention but baseline information about decisional conflict in 
this setting is not well-described. 
3.7. Conclusion 
Women with early stage breast cancer may move quickly from being part of the 
“healthy” population completing cancer screening or follow-up to becoming a person 
diagnosed with cancer. Surgical decisions occur rapidly and decisional conflict may 
affect the decisions which are made and may affect the quality of those decisions.  
Decisional conflict measurement may also be useful for interventional research in this 
setting and may promote the opportunity for high-quality surgical decision making 
among women with early stage breast cancer.  
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Table 3.1 
 
Characteristics of Decisional Conflict Scales 
  
Decisional Conflict Scale 
 
 
SURE 
Format Statement Question Question  Low Literacy Version Question 
Total Number of Items 16 16 10 4 
Responses 
Strongly Agree = 0 
Agree = 1 
Neither Agree nor 
Disagree = 2 
Disagree = 3 
 Strongly Disagree = 4 
Yes = 0 
Probably Yes = 1 
Unsure = 2 
Probably No = 3 
No = 4 
Yes = 0 
Unsure = 2 
No = 1 
Yes = 1 
No = 0 
Scoring 
Scores are summed, 
divided by 16 and 
multiplied by 25. 
 
Range from 0 to 100 
Scores are summed, 
divided by 16 and 
multiplied by 25. 
 
Range from 0 to 100 
Scores are summed, 
divided by 10 and 
multiplied by 25. 
 
Range from 0 to 100 
Can only be 
calculated if all are 
answered 
 
Scores are summed 
 
Range from 0 to 4 
Score Interpretation Scores >37.5 indicate high Decisional Conflict   
Scores ≤ 3 indicate 
high Decisional 
Conflict 
Sample Items “I feel sure about what to choose” 
“Do you feel sure 
about what to 
choose?” 
“Do you feel sure about 
what to choose?” 
“Do you feel SURE 
about the best choice 
for you?” 
Based on information from: (Legare et al., 2010; A.M. O'Connor, 1993; Annette M. O'Connor, 1995)  
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Table 3.2 
 
Summary of Reliability and Validity of the Decisional Conflict Scale (DCS) 
First Author 
(Year) 
DCS Format Sample Reliability Validity and Factor Analysis 
O’Connor 
(1995)(Annette 
M. O'Connor, 
1995) 
Statement Format 
 
16-Items 
 
3 Subscales 
Health science 
students considering 
influenza 
vaccinations (n=45) 
 
Healthcare 
employees 
considering influenza 
vaccinations (n=115)  
 
Patients with cardiac 
and respiratory 
problems considering 
influenza 
vaccinations (n=283) 
 
Women ages 50-69 
considering breast 
cancer screening 
(n=360) 
Total Scale: 
• Test-Retest correlation 
coefficient (tested in health 
science students) = 0.81 
• Cronbach alpha ranged 
from 0.78—0.92 (tested in 
all groups) 
  
Subscale Cronbach alpha: 
• Uncertainty = 0.73-0.92 
(tested in all groups) 
• Effective decision making = 
0.77-0.86 (tested in all 
groups) 
• Factors contributing = 0.58 
(cardiac/respiratory 
patients) and 0.70 (women 
considering breast 
screening)  
Known groups approach tested in 
group of health science students 
showed statistically significant 
difference (p < 0.001) 
 
Hypothesis testing conducted in the 
breast cancer screening group, DCS 
scores were inversely correlated to 
knowledge tests about breast cancer 
(Pearson r = -0.16, p<0.05)        
Koedoot 
(2006) 
(Koedoot et al., 
2001) 
Statement Format 
 
16-Items 
 
3 Subscales 
Women with 
metastatic cancer 
considering palliative 
chemotherapy (n=29) 
 
Women with early-
stage breast cancer 
choosing between 
mastectomy or 
lumpectomy (n = 
Total Scale not reported 
 
Subscale Cronbach alpha (both 
groups): 
• Uncertainty = 0.61 
(metastatic cancer group) 
and 0.75 (early-stage breast 
cancer group) 
• Effective decision making = 
0.83 (metastatic cancer 
Known groups approach showed 
statistically significant difference  in 
the metastatic cancer group for all 
three subscales and showed 
significant differences for the 
uncertainty (p <0.001) and factors 
contributing (p <0.001) subscale 
among women with early-stage 
breast cancer 
 
Table 3.2 (Continued) 
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141) group) and 0.81 (early-stage 
breast cancer group) 
• Factors contributing = 0.77 
(metastatic cancer group) 
and 0.83 (early-stage breast 
cancer group)  
Factor analysis resulted in a 4-factor 
model explaining 67.5% of the 
variance 
Katapodi 
(2011) 
Statement Format 
 
16-Items 
 
3 Subscales 
Women with cancer 
participating in 
hereditary breast 
and ovarian genetic 
testing  (n = 200) 
Total Scale: 
• Cronbach alpha = 0.96 
 
Subscale Cronbach alpha reported 
for modifications of the DCS 
subscales post Factor Analysis: 
• Knowledge about the 
decision = 0.97  
• Lack of autonomy in 
decision making = 0.94 
• Lack of confidence in 
decision making = 0.87 
Factor Analysis resulted in 3-factor 
model explaining 82% of the 
variance. 
O’Connor 
(1993)(A.M. 
O'Connor, 
1993) Updated 
2010 
Question Format 
 
16-Items 
 
5 Subscales 
Breast Cancer 
Back Surgery 
Hip and Knee 
Surgery 
PSA Testing 
Reported as “currently being tested” Reported as “currently being tested” 
Lam 
(2012)(Lam et 
al., 2012) 
Question Format 
 
16-Items 
 
5 Subscales 
Newly diagnosed 
breast cancer 
patients, prior to 
consultation with a 
surgeon (n = 471) 
Total Scale reported on a modified, 
14-item version of a 3-factor scale: 
• Cronbach alpha = 0.81 
 
Subscale Cronbach alpha reported 
on modifications of DCS subscales 
post Factor Analysis: 
• Uncertainty and Effective 
Decisions = 0.71 
• Informed and Values 
Clarity = 0.87 
Known groups approach (tested on 
modified 14-item DCS with 3 
subscales) showed statistically 
significant differences for the total 
scale and all subscales 
• Total Scale p <0.001 
• Subscale: Uncertainty and 
Effective Decisions p 
<0.001 
• Informed and Values 
Clarity Subscale, p = 0.025 
Table 3.2 (Continued) 
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• Support = 0.51 • Support Subscale, p<0.001 
 
Hypothesis Testing: 
The 14-item DCS and the modified 
3-factor subscales showed positive 
correlations with anxiety and 
depression as measured with the 
Hospital Anxiety and Depression 
Scale (r ranging from 0.20 – 0.42 
for anxiety and 0.20 – 0.41 for 
depression, p<0.05). 
 
The 14-item DCS and the modified 
3-factor subscales showed negative 
correlation with patient satisfaction 
with medical consultation as 
measured by the Treatment Decision 
Making Difficulties Scale (r ranging 
from -0.37 to -0.52, p <.05) 
 
Factor Analysis of the 14-item DCS 
resulted in 3-factor model 
explaining 53% of the variance.  
Mancini 
(2006)(Mancini 
et al., 2006) 
Format not 
identified 
 
16-Items 
 
5 Subscales 
Women with cancer 
considering genetic 
testing (n = 553), 
control group 
divided into two 
samples (n = 134 
and n = 125), 
experimental group 
(n = 294) 
Total Scale: 
• Cronbach alpha = 0.905-
0.916 
 
Subscale Cronbach alpha: 
• Uncertainty = 0.764-0.823 
• Informed = 0.842-0.883 
• Values Clarity = 0.67-0.703 
• Support = 0.441-0.593 
• Effective Decision = 0.838-
0.892 
 
Factor Analysis resulted in 4-factor 
model with support dimension part 
of informed dimension 
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O’Connor 
(1993)(A.M. 
O'Connor, 
1993) Updated 
2010 
Low- Literacy 
Question Format 
10-items 
4 Subscales 
Women with breast 
cancer (n = 63) 
 
 
Total Scale: Cronbach alpha = 0.86  
 
 
 
Not reported 
Linder 
(2011)(Linder 
et al., 2011) 
Low- Literacy 
Question Format 
10-items 
4 Subscales 
Men eligible for 
prostate cancer 
screening (n = 149) 
tested at two time 
intervals. 
Cronbach alpha > 0.80 for total 
DCS and for interclass (subscale) 
correlation coefficients and for all 
subscales except the Supported 
subscale (Cronbach alpha = <0.60) 
 
 
Known groups approach showed 
statistically significant difference (p 
< 0.001) 
Factor analysis resulted in four-
factor model with one Support 
Subscale item not loading on any 
factor and another item showed 
cross-loading.  
Based on information from:  (Koedoot et al., 2001; Lam et al., 2012; Linder et al., 2011; Mancini et al., 2006; A.M. O'Connor, 1993; Annette M. 
O'Connor, 1995) 
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CHAPTER FOUR: 
Factors Influencing Preference for Surgical Choice among Women with Early Stage 
Breast Cancer 
4.1. Introduction 
A consensus conference statement was released by The National Institute of 
Health in the 1990’s to address treatment of early-stage breast cancer.  Multiple 
prospective randomized trials comparing breast conserving surgery (lumpectomy) and 
mastectomy had demonstrated no statistical difference in survival (McGuire et al., 2009).  
In the statement, breast conserving surgery (BCS) was recognized as an appropriate 
treatment for the majority of women with early stage disease and was deemed 
“preferable” to mastectomy (National Institutes of Health, 1991, p. 394).  Significant and 
widespread practice adoption of BCS was expected once surgeons could allow women to 
choose a breast conserving approach (Balch & Jacobs, 2009).  Mastectomies continued to 
be performed in substantial numbers however, ranging from 30% to over 50% of cases in 
reported series (Chagpar et al., 2006; Collins et al., 2009; Nattinger, Gottlieb, Veum, 
Yahnke, & Goodwin, 1992).  
After the consensus statement was released, several states enacted legislation 
mandating provision of information and unbiased discussion of surgical treatment 
alternatives in breast cancer. Those policy initiatives were advocacy efforts undertaken to 
promote informed consent with the anticipated result of increased BCS utilization.  It was 
assumed that if women were given the choice, they would choose BCS in greater 
numbers (Lantz, Zemencuk, & Katz, 2002).  Within the medical community, BCS rates 
are viewed as indicators of quality (Katz & Hawley, 2007).  In addition, national 
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accreditation standards monitor rates of BCS, recommending that at least 50% of surgery 
for all eligible, early stage breast cancer patients should be BCS (National Accreditation 
Program for Breast Centers, 2017).  
In recent years,  increasing rates of mastectomy with contralateral prophylactic 
mastectomy (CPM) have been reported among women with unilateral, early stage breast 
cancer (Dragun et al., 2013; Jones et al., 2009; King et al., 2011; Tuttle et al., 2007; 
Tuttle et al., 2009).  The prophylactic surgery, i.e. removal of the contralateral breast, 
decreases the risk of contralateral breast cancer yet confers no survival advantage 
(Lostumbo, Carbine, & Wallace, 2010).  If eligible for a choice between surgical options, 
a woman’s decision becomes one of preference in a decision making process that is 
poorly understood.  
From multiple retrospective reviews of national and single-institution databases, 
several predictors of the surgical choice for mastectomy with CPM have been identified. 
These predictors have fallen into the categories of demographic and clinical factors. 
Younger age, higher level of education, positive family history of breast cancer, 
white/Caucasian/nonHispanic ethnicity, positive BRCA1 or 2 status and having a 
personal history of breast cancer have been associated with the choice of bilateral 
mastectomy.  Tumor characteristics such as size, invasion, histology, receptor and lymph 
node status have been identified as predictors (Arrington, Jarosek, Virnig, Habermann, & 
Tuttle, 2009; Damle et al., 2011; Guth et al., 2012; Jones et al., 2009; King et al., 2011; 
Stucky, Gray, Wasif, Dueck, & Pockaj, 2010; Tuttle et al., 2007; Tuttle et al., 2009; Yi et 
al., 2009).  In addition, the use of preoperative breast magnetic resonance imaging (MRI)  
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and genetic counselling have been associated with the choice of mastectomy with CPM 
(King et al., 2011; Sorbero, Dick, Beckjord, & Ahrendt, 2009; Stucky et al., 2010). 
In retrospective reviews using surveys and interviews with women after surgical 
treatments have been completed, factors of a more personal nature have been identified.  
Fear or worry about recurrence and second breast cancer, distress and anxiety have been 
described as important, and in some studies, as associated with the choice of bilateral 
mastectomy (Beesley, Holcombe, Brown, & Salmon, 2013; Han et al., 2011; Hawley et 
al., 2014; Jagsi et al., 2017; Pedersen et al., 2010; Rosenberg et al., 2015; Rosenberg et 
al., 2013; Soran et al., 2015; Spittler, Pallikathayil, & Bott, 2012).  Quality of life issues 
such as body image and concerns about cosmetic surgical outcomes have also been 
described as part of this preference-sensitive treatment decision (Baptiste et al., 2017; 
Beesley et al., 2013; Buchanan et al., 2016; Fisher et al., 2012; Spittler et al., 2012).  In 
addition, women have identified desire to avoid radiation therapy and more frequent 
medical visits as part of their reasons for choosing mastectomy with CPM (Baptiste et al., 
2017; Fisher et al., 2012; Han et al., 2011).  Factors as yet unknown may contribute to 
surgical decision-making.  Studies using prospective designs may provide needed 
information.  The purpose of this exploratory study is to prospectively identify 
demographic, clinical, cognitive and affective factors influencing a woman’s decision to 
choose either breast conserving surgery (BCS) or mastectomy with CPM and to identify 
self-reported sources of information in the surgical decision-making process. 
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4.2. Research Questions 
The following research question will be addressed: What factors influence a 
woman’s choice between two surgical options, BCS and mastectomy with CPM 
following a diagnosis of early stage breast cancer and prior to surgical treatment? 
Specific research aims are: 1) to examine differences between women choosing 
two surgical options (breast conserving surgery and mastectomy with CPM) related to the 
following factors:  demographics, diagnostic processes, tumor characteristics, depression, 
anxiety, stress, distress, breast cancer specific distress and decisional conflict,  2) to 
examine differences in breast surgery beliefs and expectations between women choosing 
between the two surgical options and, 3) to identify information sources important to 
women in the decision-making process.  
4.3. Conceptual Framework   
 The Ottawa Decision Support Framework, a conceptual model for shared decision 
making, served as an organizing framework for this study.  In the model, the desired 
outcome of shared decision making is a quality decision, described as one based on both 
the best scientific evidence and on patient values.  Positive outcomes such as minimized 
decisional delays and post-decisional regret are purported to result from quality decisions.  
Within the framework, participants in the decision making process have decisional needs 
which may include conflict, expectations, and specific personal and clinical 
characteristics (Ottawa Hospital Research Institute, 2015).  Decisional needs are 
modifiable with decision support interventions that provide information, clarify needs 
and values, and facilitate progress (Légaré, O'Connor, Graham, Wells, & Tremblay, 
2006).    
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4.4. Study Design  
 This prospective, exploratory, cross-sectional, mixed-methods study was designed to 
gather information during the time period in which surgical decision-making occurred. 
Both participant self-report and medical record information were collected. The study 
was approved by the Baptist Health Lexington Institutional Review Board and oversight 
agreement was given by the University of Kentucky Office of Research Integrity.   
 Immediately prior to enrollment, women were examined by a breast surgeon and 
completed a surgery decision-making consultation visit with the surgeon and breast 
cancer nurse navigator.  Enrollment in this manner allowed confirmation of early stage 
disease. In addition, eligibility for choice among the surgical options was confirmed by 
the surgeon.  Other inclusion criteria included unilateral breast carcinoma, older than 18 
years of age, able to read and understand English and with no personal history of cancer 
with the exception of non-melanoma skin cancer.   
4.4.1 Sample and setting. 
An a priori power analysis was conducted. Based on a moderate effect size of 0.5, 
alpha of 0.05 and power of 80%, a sample size of 128 was planned, 64 in the group 
choosing BCS and 64 in the group choosing mastectomy with CPM. Enrollment began in 
August 2016 and continued to August 2017 (n = 112).  Sixteen participants (14%) did not 
return completed questionnaires.  Eight chose unilateral mastectomy and were excluded 
from this analysis.  Ten (9%) were ineligible after enrollment: two participants had a 
prior history of cancer and were inadvertently enrolled, one completed the survey after 
surgery was completed, and eight were subsequently found on further workup to have 
either bilateral breast cancer, locally advanced Stage III disease or multifocal disease 
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making them ineligible.  For analysis, n = 78 including 47 in the BCS group and 31 in the 
bilateral mastectomy (BM) group. All other parameters remaining the same, a repeated 
power analysis of these unequal groups reveals a post-hoc power of 57%. Less than 5% 
of those invited declined to participate.  
The setting for the study was a 391-bed community hospital and an affiliated, 
seven-surgeon group office practice.  Patients were eligible for enrollment consecutively, 
on the day of consultation with the breast surgeon and immediately after the surgical 
decision-making conference occurred with the breast surgeon and breast nurse navigator. 
A study investigator approached potential participants in a private area of the physician 
office to explain the study and obtain informed consent to participate.  If a surgical 
decision had been made, enrolled patients were offered the option to complete the study 
packet at that time and were given a $10.00 gift card.  If a surgical decision had not been 
made at that point or as the patient requested, participants were provided with the packet 
and a stamped, postage-paid return mailing envelope.  Verbal and written instructions 
were provided including a reminder to complete the study packet after a surgical decision 
was made but prior to the surgery.  The principal investigator tracked enrolled 
participants who had not returned packets and completed a minimum of one reminder 
telephone call to participants as needed.  Instruction to complete the packet after a 
decision had been made and prior to surgery was included in reminder phone calls.  
Participants completing and returning packets were provided with a $10.00 gift card 
mailed to the participant in a self-addressed envelope.   
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4.4.2 Variables and measures. 
Participants were given a packet that contained: demographic questionnaire, items 
pertaining to Gail risk calculation, Depression Anxiety Stress Scale, Impact of Event 
Scale, Decisional Conflict Scale, Breast Surgery Beliefs and Expectations Scale, list of 
Information Sources, open-ended prompt and question about intention (Appendix). This 
packet could be completed in approximately 15 – 20 minutes.  Medical record 
information was abstracted from the electronic medical record by the principal 
investigator. 
4.4.2.1 Personal, demographic and clinical information. 
 The following demographic information was retrieved from participants: age, 
race, marital status, level of education, employment status, income level, insurance status, 
personal and family history.  Clinical information was collected from the medical record 
and included: breast imaging information including MRI and post-MRI biopsies, genetic 
counselling consultation, genetic testing results and pathologic features of surgical 
specimens including tumor prognostic indicators such as receptor status, histology and 
grade.  
4.4.2.2 Depression, Anxiety and Stress Scale. 
The Depression Anxiety Stress Scale (DASS) consists of a total of 42 items to 
which respondents are asked to signify an answer on a four-point scale ranging from 0 
(did not apply to me at all) to 3 (applied to me very much or most of the time). 
Participants are asked to include experiences from the preceding week when responding. 
Fourteen items of the DASS pertain to depression, 14 to anxiety and 14 to stress and 
items for each of these three subscales are interspersed among the other subscale items. 
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Reported mean scores in a normative, non-clinical sample include: total score M= 18.38 
(SD = 18.82), depression subscale M = 5.55 (SD = 7.48), anxiety subscale M = 3.56 (SD 
= 5.39) and stress subscale M= 9.27 (SD = 8.04).  Higher scores represent higher 
depression, anxiety and stress on the representative subscale and overall distress for the 
total score.  Levels of symptom severity have been established with severe levels defined 
as:  depression score > 20, anxiety score > 14 and stress score > 26 (Crawford & Henry, 
2003).  
The DASS has been found to have high reliability in prior studies.  Cronbach 
alpha for the overall DASS have been reported in the range of 0.84-0.97 for the total 
DASS and for the three subscales (Crawford & Henry, 2003; Lovibond & Lovibond, 
1995).  In this study reliability was high, with coefficient alpha ranging from 0.86-0.96 
for the overall and three DASS subscales.  
4.4.2.3 Impact of Event Scale. 
 The Impact of Event Scale (IES) is a self-report measure of distress associated 
with a serious life event.  With identification of a specific event within the instructions 
for completing the IES, the scale was linked with the personal experience of breast cancer 
for each participant.  Fifteen questions are divided among two subscales, intrusion and 
avoidance.  The intrusion subscale contains seven items and the avoidance subscale 
contains eight items. Each item asks the respondent to consider how frequently the item 
was true in the past seven days.  Items are rated on a four-point Likert scale ranging from 
“not at all,” “rarely,”, “sometimes,” to “often.”   Items are scored as 0, 1, 3, and 5 
respectively.  The resulting range of scores for each scale is 0 to 35 for the intrusion 
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subscale and 0 to 40 for the avoidance subscale (Epping-Jordan et al., 1999).  Higher 
scores represent higher breast-cancer specific distress.  
Acceptable reliability has been reported with the IES.  In the breast cancer 
population specifically, coefficient alpha levels of 0.90 for the total scale, 0.70-0.71 for 
the intrusion scale and 0.83-0.85 for the avoidance subscale have been reported (Epping-
Jordan et al., 1999; Miller, Schnur, Weinberger-Litman, & Montgomery, 2014).  In this 
study, acceptable coefficient alpha was 0.93 for the IES total, 0.89 for the intrusion 
subscale and 0.87 for the avoidance subscale. 
4.4.2.4 Decisional Conflict Scale. 
The Decisional Conflict Scale (DCS) consists of 16 total items in statement 
format.  Responses are made using a five point Likert scale ranging from 0 (strongly 
agree) to 4 (strongly disagree).  Responses are summed, divided by 16 and then 
multiplied by 25, resulting in a decisional conflict score ranging from 0 to 100.  Low 
scores represent low decisional conflict and high scores represent high decisional 
conflict.  Scores above 37.5 are associated with feeling unsure about the decision and 
with decisional delay (O’Connor, 1995).  Coefficient alpha for the scale in previous 
studies ranges from 0.78—0.92, demonstrating acceptable internal consistency 
(O’Connor, 1993).  The five subscales of the DCS include: informed, values clarity, 
support, uncertainty and effective decision.  Three items make up each subscale except 
for the effective decision subscale which is comprised of four items.  High subscale 
scores represent high decisional conflict in that specific area.   
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4.4.2.5 Breast Surgery Beliefs and Expectations Scale. 
In order to assess the way in which women think about breast surgery options, a 
measure of the beliefs and expectations was developed.  Items for the scale were drawn 
from the primary investigator’s clinical experience and from previous published 
assessments of disease-specific knowledge (Collins et al., 2009; Fagerlin et al., 2006; 
Sepucha, Ozanne, Silvia, Partridge, & Mulley, 2007).  The Breast Surgery Beliefs and 
Expectations Scale (BS-BES) included nine items to which participants were asked to 
assign a level of importance using a Likert scale ranging from 1 (not at all important) to 4 
(very important).  Higher scores on each item represented higher importance of that item 
in the surgical decision.   
The BS-BES was reviewed by three oncology nurses prior to use.  A breast cancer 
nurse navigator, oncology clinical nurse specialist and oncology nurse read the items to 
evaluate clarity, measurement format and with consideration of the scale’s intent. 
Revisions were made for clarity and concision.  
4.4.2.6. Information sources. 
Participants were asked to identify sources of information in their surgery 
decision-making process.  A list of information sources was developed from the 
investigator’s clinical experience and from published reports (Covelli, Baxter, Fitch, 
McCready, & Wright, 2014; Dickerson, Alqaissi, Underhill, & Lally, 2011; Lally, 2009; 
Spittler et al., 2012).  Women were provided an opportunity to add sources not found on 
the list and asked to delineate the most influential source among their list.  
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4.4.2.7 Intention. 
Intention to choose either BCS or mastectomy with CPM was assessed using a 
single question.  Participants were asked to respond “yes” or “no” to the question, “Did 
your initial intent regarding surgery match your final decision?” 
4.4.3 Open-ended prompt. 
 Given the lack of prospective studies, the opportunity to explore personal, self-
generated information was important.  An open-ended prompt asking for comments about 
the reason for the surgical choice was provided.  
4.5. Data Analysis 
Data analysis was performed using IBM SPSS®  Statistics (version 24).  
Frequency distributions were used to examine all variables including outliers and 
distributions.  Descriptive statistics including means, standard deviations and frequency 
percentages were used to characterize the total sample and both subgroups as appropriate.   
Categorical and continuous level data for demographic, clinical and diagnostic 
characteristics as well as information sources and intention were analyzed using 
independent sample t-tests and chi-square tests as appropriate to the level of data.  Odds-
ratios were calculated. For those categorical variables in which cell counts were less than 
five, Fisher’s exact test was used to compare groups.  
Total scores and subscales scores of the DASS, IES and DCS for each group were 
compared. Independent t-tests were used to compare total scale and subscale data.  Given 
the exploratory nature of this study a Bonferroni correction was not calculated.  
Factor analysis was performed on the investigator-designed BS-BES to evaluate 
the shared variance of the nine items.  The factor analysis provided the basis for 
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identifying three subscales within the instrument. Suitability assumptions for factor 
analysis were met in number of response options of at least three and ten cases per item.  
The sample size was 77 for this scale, which is below the minimum recommended for 
factor analysis.  Bartlett’s test of sphericity was used to test the correlation matrix and 
Kaiser-Meyer-Olkin (KMO) was used to evaluate matrix sample adequacy.  A KMO 
value greater than 0.5 was considered minimally acceptable.  Principal component 
analysis extraction with varimax rotation was performed. Items were identified to a factor 
with loadings greater than 0.40.  Cross-loaded factors were defined as those loading on 
more than one factor.   
4.6. Results 
4.6.1 Research Aim 1: To examine differences between women choosing two 
surgical options (breast conserving surgery and mastectomy with contralateral 
prophylactic mastectomy) related to the following factors:  demographics, 
diagnostic processes, tumor characteristics, depression, anxiety, stress, distress, 
breast cancer specific distress and decisional conflict.  
4.6.1.1 Demographic, diagnostic and clinical factors. 
Demographic characteristics of the sample and subgroups are summarized in 
Table 4.1. The participants were 57 (SD 12) years of age on average, almost exclusively 
Caucasian (94%), and the majority were married/partnered (66%).  The majority of 
participants had an education level greater than a high school education with 49% 
completing some college or university study and 20% completing some graduate level 
education.  Sixty percent of participants were employed full- or part-time and 77% 
reported an income level greater than or equal to, $40,000 per year.  Only four women in 
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the study reported having Medicaid and all of those women elected to have BCS.  A 
statistical comparison of groups was not able to be completed for insurance status due to 
distribution of this variable.  
A significant difference was found for age (t(77) = 5.098, p < .001, r = .59) and 
employment (χ2 (1) = 3.78, p < .05) between women choosing BCS and women choosing 
mastectomy with CPM.  Women choosing mastectomy with CPM were 12 years younger 
on average (M 50, SE = 1.9) as compared to those choosing BCS (Μ 62, SE = 1.5). 
Those who worked either full or part-time were 2.6 times more likely to choose bilateral 
mastectomy.  There were no differences in race, marital status, education level and 
income.  
 Diagnostic factors are shown in Table 4.2.  The total sample was evenly divided 
between those who did and did not complete preoperative breast MRI.  In comparing the 
groups however, different distributions are seen with 60% of women in the BCS group 
and 35.5% of women in the bilateral mastectomy group completing preoperative imaging 
with breast MRI.  The majority of participants (58%) did not complete genetic counseling 
but distribution differences in the subgroups are again noted.  In the BCS group, 28% 
completed genetic counseling and in the mastectomy with CPM group, 64.5% completed 
genetic counseling.  The majority of the total sample and each subgroup did not require a 
post-MRI biopsy, did not have genetic testing, did not have a family history in first 
degree relatives and were not defined as high-risk prior to diagnosis as calculated by the 
Gail risk model.  
Statistically significant differences were found between the groups for 
preoperative breast MRI and genetic counseling.  Among those who did have 
 53 
 
preoperative breast MRI, women were 2.68 times more likely to choose BCS, χ2 (1) = 
4.336, p < .05 and among those who had preoperative genetic counseling, women were 
4.8 times more likely to choose bilateral mastectomy as compared to BCS χ 2 (1) = 
10.396, p < .01 (Table 4.2).   
 Clinical characteristics are shown in Table 4.3. The mean tumor size was 1.5 cms 
(SD 1.2) in largest dimension.  Those choosing bilateral mastectomy had tumors 
averaging 2.2 cms in largest dimension as opposed to an average size of 1.1 cm in the 
BCS group, t(76) = -4.343, p < .001, r = .4.  Tumor size was the only variable with a 
significant difference between the groups in terms of clinical characteristics. Most tumors 
were invasive or in situ ductal carcinomas (91%), lymph node negative (74%), ER/PR 
positive (95/96%) and HER2-neu negative (72%).  
 4.6.1.2 DASS, IES, and DCS Scores and Subscale Scores. 
 The properties of DASS, IES and DCS scales and subscales are outlined in Table 
4.4.  Cronbach coefficient alpha > 0.70 was considered acceptable.  All scales and 
subscales met criteria for acceptable reliability with the exception of the uncertainty DCS 
subscale (α = 0.67).  
 Overall, mean DASS total scores and subscores were within the normal range 
criteria (Table 4.4).  Only six (8%) and nine (12%) participants reported greater than 
moderate levels of depression and anxiety, respectively.  No participants reported stress 
above moderate levels (Table 4.5). 
 Breast cancer specific distress measured by the IES, resulted in the following 
mean scores for the sample as a whole (Table 4.4):  IES-total (M = 28.20; SD 18.54), 
IES-Intrusion (M = 13.52; SD 9.49) and IES-Avoidance (M = 14.59; SD 10.17).  Scores 
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greater than 26 indicate a stress impact in the moderate to severe range (Horowitz, 1994). 
The two items with the highest proportion of “sometimes” and “often” scores were items 
four, “I had trouble falling asleep or staying asleep because of pictures or thoughts about 
it that came into my mind” and five, “I had waves of strong feelings about it.”  Twenty-
two and 19 women reported sometimes and often experiencing items four and five 
respectively.  Among all participants, 39 (50%) demonstrated a moderate to severe 
impact from the breast cancer diagnosis (IES score > 26).  A greater percentage of 
women reported an IES score 26 or above in the mastectomy with CPM subgroup (58%) 
as opposed to the BCS group (45%). 
 The total DCS score (M = 9.10; SD 12.62) was low; well below the 37.5 score 
indicative of decisional delay or insecurity with the decision.  DCS subscales scores were 
all low with the highest score noted on the Uncertainty Subscale (M = 14.85; SD 17.29) 
(Table 4.4). 
 DASS, IES and DCS total scores and subscale scores for the subgroups, women 
choosing BCS and women choosing mastectomy with CPM were compared (Table 4.6).  
DASS and IES scores were higher on average for women in the bilateral mastectomy 
group as compared to those in the BCS group. DCS total and subscale scores, with the 
exception of the uncertainty subscale, were the opposite.  Women in the BCS group had 
higher total decisional conflict and had higher DCS subscale scores with the exception of 
the uncertainty subscale for which women in the bilateral mastectomy group had higher 
mean scores.  
 Statistically significant differences with small to medium effect size were found 
in DASS Anxiety Subscale and in the intrusive impact of the diagnosis as measured by 
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the IES-Intrusion subscale.  Women in the mastectomy with CPM group were more 
anxious on average (M = 7, SE = 0.7) than women choosing BCS (M = 4, SE = 0.7), 
t(75) = -2.298, p < .010, r = .25.  Breast cancer specific distress as measured by the IES-
Intrusion Subscale, was higher in the group choosing mastectomy with CPM (M 17, SE 
1.7) as compared to those choosing BCS (Μ 11, SE 1.2), t(75) = -2.852, p < .01, r = .31.  
 Decisional conflict was higher among women choosing BCS.  Statistically 
significant differences between the two subgroups were found for the DCS scale as a 
whole and for the values clarity, support and effective decision subscales.  Effect sizes 
were small.  Mean decisional conflict scores for women choosing BCS were 10 (SE = 
2.2) as compared to mean scores of 8 (SE = 1.4) for those choosing mastectomy with 
CPM, t(76) = 0.9, p < .05, r = .10.  Women choosing BCS were more unclear about 
personal values in the decision making (M 7, SE = 2.6) as compared to those choosing 
mastectomy with CPM (Μ 4, SE = 2.1), t(76) = 1.613, p ≤ .05, r = .18.  They also felt 
more unsupported in their decision making (M 7, SE = 2.1) as compared to those 
choosing mastectomy with CPM (Μ 4, SE = 1.4), t(76) = 1.230, p ≤ .05, r = .14.  Women 
choosing BCS reported higher scores for ineffective decisions (M 10, SE = 2.3) as 
compared to those choosing bilateral mastectomy (Μ 6, SE = 1.6), t(76) = 1.340, p ≤ .05, 
r = .15. 
4.6.2 Research Aim 2:  To examine the differences in breast surgery beliefs 
and expectations between women choosing two surgical options (breast conserving 
surgery and mastectomy with contralateral prophylactic mastectomy).  
The BS-BES was an investigator-designed scale, used for the first time in this 
study.  A summary of all responses to the nine-item scale is provided in Table 4.7.  Over 
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80% of participants rated the items “minimize the chance of breast cancer coming back” 
and “minimize the chance of dying from breast cancer,” as very important. Forty-nine 
and 47% of participants rated the item “avoid the need for future mammograms/breast 
screening” and “have the option to improve my breasts through reconstruction” as not at 
all important.  
A factor analysis was conducted for the nine-item scale, which met requirements 
for number of response criteria and number of cases per item.  Bartlett’s test of sphericity 
was significant (p < .001).  The null hypothesis that the correlation matrix is an identity 
matrix is rejected. Minimal matrix sample adequacy was met (KMO = .636) and the 
determination of the correlation matrix was adequate (.077).  
Factor Analysis with Varimax Rotation was performed.  A cut point of .40 was 
used to define factor loading and cross-loaded factors were defined as those which loaded 
similarly on more than one factor.  Three factors are represented in the subscale (Table 
4.8), a Mastectomy Factor (Factor 1), a Recurrence/Survival Factor (Factor 2) and a BCS 
Factor (Factor 3).  The Mastectomy Factor is made up of four items: “remove breast for 
peace of mind,” “avoid radiation,” “avoid the need for future mammograms/breast 
screening,” and “have the option to improve my breasts through reconstruction.”  The 
Recurrence/Survival Factor is made up of two items, one about minimizing the chance of 
recurrence and one about minimizing the chance of dying from breast cancer.  The BCS 
Factor consists of two items related to the choice of BCS, “do as little surgery as 
possible” and “keep my breast.”  One factor of the nine, “minimize the length of 
treatment,” crossloaded on both the Mastectomy Factor and the BCS Factor and was 
removed from analysis. 
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Higher scores represent higher importance for each item on this scale.  Higher 
factor scores, therefore represent higher importance for that factor.  Scores for each factor 
were compared across subgroups.  Significant differences were found in all three 
comparisons.  Mastectomy factor scores were greater for women choosing bilateral 
mastectomy (M 12, SE .5) than those choosing BCS (M 7, SE .5), t(75) = -6.240, p < 
.001, r = .58.  Recurrence/Survival Factor scores were also higher among women 
choosing bilateral mastectomy (M 7.96, SD 0.2) than those choosing BCS (M 7.29, SD 
1.2), t(75) = p < .001, r = .24.  In contrast, BCS Factor scores were higher among women 
choosing BCS (M 5, SE .25) than among women choosing bilateral mastectomy (M 4, SE 
.26), t(75), p < .01, r = .29.  
4.6.3 Research Aim 3:  To identify information sources important to women 
in the decision-making process.  
Sources of information identified by participants are shown in Figure 4.1 
(percentage of all participants) and Figure 4.2 (percentage of each subgroup participants). 
One hundred percent of the participants in this study identified their surgeon as an 
information source in the decision-making process.  The top five information sources (by 
%) were similar between the two groups.  For the BCS group, the top five were: 1) 
surgeon, 2) family, 3) nurse navigator, 4) friends and 5) spouse/partner.  For the bilateral 
mastectomy group, the top five were: 1) surgeon, 2) nurse navigator, 3) family, 4) 
spouse/partner and 5) friends. Nine women choosing BCS wrote in an additional 
information source.  The breast MRI was added as an information source by three 
women. Genetic counselling, medical oncologist, “God/Jesus/Prayers,” and “other breast 
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cancer survivors,” and “myself” were each added by one participant.  No additional 
information sources were provided by women choosing mastectomy with CPM.   
Participants were asked to identify the most influential information source among 
those identified.  Spouse/partner and family categories were collapsed into one category 
for analysis.  There were significant differences between the groups identifying the most 
influential information source (Table 4.9).  The odds of a woman with early stage, 
unilateral breast cancer choosing BCS were 6.4 times more likely if she identified the 
surgeon as the most influential, X2 (1) = 10.397, p < .05. The odds of a woman with the 
same diagnosis choosing mastectomy with CPM were 4.1 times more likely if she 
identified spouse and family as the most influential, X2 (1) = 5.964, p < .05.  
4.6.4 Intention  
On the questionnaire, a yes/no question was asked regarding intention, “did your 
initial intent regarding surgery match your final decision?”  Sixty-one (78%) of the 
participants answered “yes” to that question.  There was no statistically significant 
difference between the groups as analyzed by chi-square.  
4.6.5 Comments 
Participant comments were invited with the prompt, “In your own words, please 
describe the reason for your surgical choice.”  All participants provided at least one 
handwritten response.  Comments were extracted verbatim and compiled into lists sorted 
by breast surgery.  Three reviewers, two of whom have extensive clinical experience with 
breast cancer patients and one of whom has an oncology research background with 
expertise in both qualitative and quantitative methods read all comments.  Initially, 
comments were examined independently by the reviewers as main ideas were identified 
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and comments were sorted accordingly.  Reviewers then met and discussed common and 
discrepant groupings until agreement was reached.  
 Among the 31 women in this study who chose mastectomy with contralateral 
prophylactic mastectomy, the most common reason cited for surgical choice was worry 
about recurrence and the “peace of mind” gained by the choice.  Twenty-three women 
described their decision in those ways including comments such as: “I wanted to not 
worry the rest of my life,”  “I’m only 40, and already worried that it would come back, “I 
want peace of mind to know I’m doing everything I can to ensure that I beat it.”  Eight 
women wrote of their concern for family as a reason for their choice with comments 
including, “I have two small children and want to be here to watch them grow up.  I know 
having me here is more important to myself, my spouse, and my children than having 
breasts” and “anything I can do to minimize having to put my family and me through this 
again is worth it.”  Eight women identified avoidance of future surveillance as a rationale, 
writing “I do not want my life to revolve around worry and mammograms in the future,” 
“no fear of a bad mammogram,” and “I don’t want to have to be watched closely with 
mammograms.” A family history was reported as a reason for the decision by five 
women.   
Less than five comments were reported in the following categories: maximizing 
survival, getting rid of the cancer, making the decision to achieve a better cosmetic 
outcome and as a means of avoiding radiation treatment.  Three women wrote of the 
relative importance of their breast with such comments as: “no real attachment to 
breasts,” “breasts don’t define who I am or enhance/diminish my self-worth,” and a 
woman who was a below the knee amputee commented “I’m OK losing another body 
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part.”  Two women reported previous issues with pain and discomfort in both breasts as a 
reason for the decision to choose bilateral mastectomies.  
Among participants choosing breast conserving surgery, the overwhelming 
majority of comments included very clinical information.  Included in this group of 23 
comments were references to the histology and stage of the individual’s cancer such as 
“cancer is in situ and not invasive.”  There were also comments about survival and 
recurrence statistics such as “the ten year prognosis between lumpectomy and 
mastectomy was no different” or “the survival rate is the exact same for each.”  Breast 
MRI and genetic testing results were also included in that category.  Fourteen comments 
made reference to the advice of, or consultation with, physicians including: “The surgeon 
explained the pros and cons of all procedures and it was best for my situation,” “primary 
care physician and surgeon both gave same advice,” “it just makes sense to take medical 
advice from physicians I trust,” and “the surgeon convinced me that lumpectomy would 
be as effective with only a small chance of the cancer returning.”  Breast conserving 
surgery was described as a means to maintain normalcy or return to normal more quickly 
and as the least invasive approach by 14 study participants.  Eight women specifically 
wrote about the desire to preserve their breast.  Five women wrote about choosing breast 
conserving surgery now with the idea that a mastectomy could be done later, for example, 
“if this cancer comes back and we have to do more radical surgery,” and “my surgeon let 
me now that I could change my mind about having a mastectomy at a later date if the 
cancer comes back.”  Two women in this group referred to mastectomies as scary and 
one woman used the term “creepy.”  
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There were differences in comments between the groups.  While both groups 
commented about their decision as pertaining to issues with recurrence of disease, the 
focus was different.  Those choosing mastectomy with contralateral prophylactic 
mastectomy wrote about recurrence in connection with emotional terms like worry and 
seeking peace of mind.  The breast conserving surgery group wrote about recurrence risk 
in a very cognitive way, citing percentages and specific clinical information and medical 
rationale.  As it pertained to lifestyle and family, rationale for the surgical choice was 
also dissimilar with women in the bilateral mastectomy group focused on avoiding future 
issues for their family and the breast conserving group writing about a short recovery 
time and quick return to normal life now.  Avoiding radiation or avoiding future 
mammograms were reported as rationale in the bilateral mastectomy group and the breast 
conserving surgery group conversely chose a surgery committing to both.  In the breast 
conserving surgery group, comments about a physician’s advice or counsel were common 
and physicians were rarely mentioned by women in the other group.  An unexpected 
rationale for bilateral mastectomies was breast pain and very few women choosing 
mastectomies spoke about cosmetic rationale such as symmetry or reconstruction.  
4.7. Discussion 
 This study demonstrated differences between women choosing among two 
surgical options as treatment for early stage breast cancer.  Age was significantly 
different between the two groups with younger women more likely to choose mastectomy 
with CPM.  This is consistent with findings from previous studies (King et al., 2011; 
Tuttle et al., 2007; Tuttle et al., 2009).  A reason may be the way in which women of 
different ages view recurrence risk and the requisite surveillance activities post-surgery.  
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Women choosing BCS, for example, have elected to preserve breast tissue and therefore 
have a local recurrence risk greater than women who have elected to have mastectomy. 
Women choosing BCS will be scheduled to participate in breast cancer surveillance 
activities (i.e. mammograms).  Choosing bilateral mastectomy decreases the risk of local 
recurrence significantly and relieves the woman of future surveillance by breast imaging.  
Mammograms from younger women with greater breast density are more difficult to 
evaluate.  Recall for diagnostic films and false positive findings are more common for 
that reason.  Younger women may be familiar with that issue already and may choose 
mastectomy in response. Age differences may be important in light of family and work 
concerns.  Women who have young children in the home or who are establishing 
themselves in the workforce may view the surgical options and recovery periods 
differently than women with older or adult children who are more established in their 
careers.   
 The majority of women in both subgroups were employed either part- or full-
time.  A meaningful finding in this study was a difference between the subgroups in 
terms of employment.  This finding is new in this area, perhaps because employment 
status is not included in cancer registry data and could therefore not be tested in 
retrospective studies drawn from cancer databases. 
 Participation in genetic counseling and preoperative breast MRI were both 
significantly different between the groups.  Participation in genetic counseling has been 
identified in previous studies as predictive of choosing mastectomy with CPM (Soran, 
Kamali Polat, Johnson, & McGuire, 2014; Stucky et al., 2010) which is consistent with 
findings in this study.  Higher rates of CPM have been associated with preoperative 
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breast MRI in previous studies (Sorbero et al., 2009; Stucky et al., 2010).  In this study, 
however, women who had preoperative breast MRI were more likely to choose BCS. 
This may be a result of changing practice patterns in the use of breast MRI. In the setting 
in which this study was conducted, breast MRI is often recommended for women prior to 
BCS to assess for multifocal and bilateral disease before undertaking a conservative 
surgical approach.  Women choosing mastectomy with CPM do not need to undergo 
breast MRI because concerns about re-excision for positive margins or diffuse multifocal 
disease are not relevant.   
The prospective design of this study allowed for observation of something not 
previously reported regarding breast MRI.  In this study, eight of the 112 participants 
were excluded from the study after positive findings on breast MRI.  Those eight women 
who had been diagnosed with early stage cancers no longer met immediate eligibility 
criteria for a choice among surgical options.  Retrospective studies are unable to gather 
this level of data and previous studies finding associations between breast MRI and 
bilateral mastectomy may include patients who are truly not eligible for a breast 
conserving approach after breast MRI.  
Overall levels of distress, depression, anxiety and stress were within normal levels for 
the participants.  This may be related to the baseline characteristics of an educated, 
insured, higher socioeconomic group of women who have support from spouses/partners. 
There was some variability in these measures within the sample, however with some 
women exhibiting high levels of distress, depression and anxiety and breast cancer-
specific distress in both subgroups.  Significant differences between the two groups were 
seen for generalized measures of anxiety and for the intrusive impact of the breast cancer 
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diagnosis; those choosing mastectomy with CPM exhibited higher levels of both as 
compared to women choosing BCS.  The lack of previous, prospective studies in this 
population provides very little comparison.  Higher perceived risk for contralateral breast 
cancer has been associated with higher levels of anxiety in one study (Portschy et al., 
2015).  In a prospective study of women with early and locally advanced, newly 
diagnosed breast cancer, total IES scores were not significantly associated with CPM.  
Subscale IES scores were not reported in that study (Parker et al., 2016).  Exploration of 
those affective factors are possible in a study of this design and the differences between 
the groups are new findings.  
Overall, the participants exhibited low decisional conflict.  In the breast conserving 
surgery group, mean DCS scores were higher and standard deviations were wider 
suggesting higher and more varied decisional conflict as compared to women in the 
mastectomy with CPM group.  Significantly higher decisional conflict was seen in the 
BCS group as compared to women choosing bilateral mastectomy.  In addition, women 
choosing BCS expressed greater lack of values clarity and support in their decision 
making and expressed higher levels of conflict in terms of effective decision-making.  
Among women electing mastectomy with CPM, previous reports have described high 
satisfaction, low decisional conflict and low decisional regret with the decision 
(Buchanan et al., 2016; Lally, 2009; Mamtani & Morrow, 2017; Moffat & Yakoub, 2016; 
Soran et al., 2014)  
 A scale was developed for this study to assess women’s beliefs and expectations 
about surgery options for breast cancer.  This is the first use of the scale; validity and 
reliability testing is warranted.  Factor analysis identified three dimensions in the scale 
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which were used to test differences between the groups.  The groups differed 
significantly for all three factors.  Woman choosing mastectomy with CPM reported 
higher importance on the mastectomy factor, women choosing BCS reported higher 
importance on the BCS factor, and women choosing mastectomy with CPM reported 
higher importance on the recurrence/survival factor.  One item on the BS-BES scale 
crossloaded on both mastectomy and BCS factors. This was unexpected.  The item, 
“minimize the length of treatment” appears to have been interpreted differently among 
the participants. It was intended to be a measure predictive of bilateral mastectomy 
choice in that mastectomy would alleviate the need for a post-surgical course of radiation 
therapy and future breast surveillance.  Participants interpreted the item differently which 
is perhaps explained by comments from women in the BCS group who reported quicker 
recovery time and return to normal as rationale for their choice of BCS.  Multiple 
reconstruction procedures may have been considered “treatment” by participants.    
 In both groups, the majority of women reported choosing the surgery they had 
originally intended to choose.  This might be related to the fact that no unexpected 
findings occurred with their workup, therefore recommendations and options remained 
stable and as expected.  It could also reflect a commitment to a choice made prior to 
consultation with the surgeon as was found in a qualitative study of women in the 
surgical decision-making process.  In that study, some women were found to have 
preferences about surgery choice that were made prior to the surgical consultation (Lally, 
2009). 
 All of the participants in the study, no matter the subgroup, identified the surgeon 
as an information source. Information sources were similar between the two groups with 
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the same top five sources identified by both groups.  An unexpected finding was the 
identification of the 6th choice for both subgroups, a professional from the breast imaging 
area.  The mastectomy with CPM group identified a breast imaging nurse and the BCS 
group identified a breast imaging radiologist as an information source.  This has not been 
reported previously and brings a new perspective to the surgical decision making process. 
The role of breast imaging professionals in this process should be further explored and 
defined. Breast imaging may be an area in which decisional support counselling and 
resources could be focused.  
In regard to the designation of the most influential information source, subgroups 
differed.  The surgeon was chosen as most influential in the BCS group and 
spouse/family were chosen as most influential in the bilateral mastectomy group.  This 
finding could be relevant in research studies and implementation of decisional support 
interventions.  The identification of family as the most influential information source 
points to the importance of decisional support that would include the family.   
When asked to provide comments about the reason for their surgical choice, all of 
the participants in the study responded.  Some participants replied with more than one 
page of comments.  Categories of comments provided a contrast between the groups. 
Recurrence was mentioned by both groups as important in their decision making but the 
way in which it was expressed was different.   Women in the bilateral mastectomy group 
wrote about recurrence in more emotional terms, associated with words like worry, fear 
and “peace of mind.”  They also expressed their surgical decision as one that was more 
future-oriented in reducing the risk of breast cancer coming back.  Women in the BCS 
group wrote about recurrence in association with medical information about their disease 
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specifically and about chance or odds.  They were more oriented to the present time, 
writing of a quicker return to normal or aversion to more extensive surgeries or even 
multiple reconstructive surgeries.  
Comments provided new information in the rationale for mastectomy related to a 
history of breast pain and very few women commented on a cosmetic rationale for 
choosing bilateral mastectomy.  A new insight into the choice of BCS was highlighted in 
comments about going through BCS first with the option of mastectomy later.  It could be 
presumed that the larger tumor size in the group of women choosing bilateral mastectomy 
might have led more women to choose the procedure because of cosmetic outcomes 
which may have been less positive with larger resections.  As evaluated by the lack of 
comments about cosmetic rationale, this does not appear to be the case.  
Comments also provided information which was used in data analysis and 
interpretation.  Women in the BCS group overwhelmingly wrote about the influence of 
the surgeon in their surgical choice while very few women in the mastectomy with CPM 
group commented about the surgeon.  The difference informed the comparison of groups 
by the information source they chose as most influential.   
4.8. Limitations 
This study was conducted in one community hospital.  The sample lacked 
diversity in terms of race/ethnicity, socioeconomic and insurance status.  Generalizations 
to other populations are a limitation.  Similarly, the healthcare setting in which this study 
was carried out may have specific procedures, standards of care or staff which may be 
unlike breast cancer care in other settings which would also limit generalization of 
findings.  
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4.9. Implications for Nursing 
Knowledge regarding predictors of decision making among women with early 
stage breast cancer is limited.  Research thus far has been largely retrospective and 
descriptive in nature.  Given the personal nature of this decision, with resulting effects on 
a woman’s body, lifestyle and emotions, the way in which women think and feel about 
the decision warrants exploration.  Prospective research, studies that are qualitative in 
nature and particularly those that allow the opportunity to explore questions more fully 
may provide much needed information about why women choose mastectomy with CPM 
or BCS.  
Patient decision making is optimized when knowledge is increased and 
participation is satisfactory to the patient (Katz & Hawley, 2007).  A better understanding 
of decision needs could impact clinical practice, perhaps optimizing decisional support 
and decision quality.  This study contributes to the body of knowledge in this area.  
Overall, women choosing either surgery were not experiencing severe levels of distress, 
depression, anxiety or stress although there were individual variations.  Women choosing 
mastectomy with contralateral prophylactic mastectomy were more anxious and had more 
frequent intrusive thoughts about the diagnosis.  They also had less decisional conflict as 
compared to women choosing breast conserving surgery.  The influence of the surgeon 
was very important for women choosing breast conserving surgery.  In contrast, family 
were the most influential among women choosing mastectomy with contralateral 
prophylactic mastectomy.  In both groups, intention for surgical choice was matched by 
the final decision.  There are many factors influencing surgical choice among women 
with early stage breast cancer.  Previous work has focused on clinical, demographic and 
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diagnostic processes influencing the decision.  With this study, evidence regarding the 
influence of cognitive and affective factors is described. 
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Table 4.1 
 
Demographic Characteristics of the Sample (n = 78) 
Demographic 
 
Total 
Sample 
(n = 78) 
Breast 
Conserving 
Surgery 
(n = 47) 
Mastectomy with 
Contralateral 
Prophylactic 
Mastectomy 
(n = 31) p 
Age (years), mean (± SD) 57 ± 12 62 ± 10 50 ± 11 .000* 
Race/Ethnicity 
Caucasian 
Non-Caucasian 
73 (94) 
5 (6) 
44 (94) 
3 (6) 
29 (93.5) 
2 (6.5) 0.99 
Marital Status 
Married/Partnered 
Divorced/Separated/Single/Widow 
Missing Data 
52 (66) 
25 (33) 
1 (1) 
30 (64) 
 16 (34) 
1 (2) 
22 (71) 
9 (29) 
0 0.60 
Education 
Elementary/High School 
College/University 
Graduate School 
Missing 
23 (30) 
38 (49) 
16 (20) 
1 (1) 
15 (32) 
24 (51) 
7 (15) 
1 (2) 
  8 (26) 
14 (45) 
9 (29) 
0 0.34 
Employment 
Full- or Part-Time  
Other 
Missing 
47 (60) 
30 (39) 
1 (1) 
24 (51) 
22 (47) 
1 (2) 
23 (74) 
8 (26) 
0 .05* 
Income 
< 40,000 
40,001 to 80, 000 
>80,000 
Missing 
16 (21) 
23 (30) 
37 (47) 
2 (3) 
   
10 (21) 
14 (30) 
21 (45) 
2 (4) 
 
 6 (19) 
9 (29) 
16 (52) 
0 .91 
Insurance 
Medicaid 
Any Commercial Insurance 
Medicare /Medicare + Supplement 
Missing 
4 (5) 
51 (65) 
22 (28) 
1 (1) 
4 (9) 
25 (53) 
17 (36) 
1 (2)   
0 
26 (84) 
5 (16) 
0 
a 
Data presented as mean ± SD or frequency (%)  
Age compared by independent t-test, Race/Ethnicity compared with Fisher’s Exact test, all 
other variables compared with Chi-square tests 
*significant p ≤ .05 
a statistical comparison of groups not completed  
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Table 4.2 
 
Comparison of Diagnostic Factors between Breast Conserving Surgery and Mastectomy 
with Contralateral Prophylactic Mastectomy (n = 78) 
Diagnostic Factors 
 
Total 
Sample 
 
(n = 78) 
Breast 
Conserving 
Surgery 
 
(n = 47) 
Mastectomy 
with 
Contralateral 
Prophylactic 
Mastectomy 
 
(n = 31) p 
 
Breast Magnetic Resonance 
Imaging (MRI) prior to surgery 
Yes 
No 
 
 
 
39 (50) 
39 (50) 
 
 
 
28 (60) 
19 (40) 
 
 
 
11 (35.5) 
21 (65.5) 
 
 
 
 
.037* 
 
Post MRI Biopsy  
Yes 
No 
17 (22) 
61 (78) 
13 (28) 
34 (72) 
4 (13) 
27(87) .122 
 
Genetic Counseling 
Yes 
No 
33(42) 
45 (58) 
13 (28) 
34 (72) 
20 (64.5) 
11 (35.5) .002* 
 
Genetic Testing Results  
Positive 
Negative 
None 
3 (4) 
30 (39) 
45 (58) 
0  
13 (28) 
34 (72) 
  3 (10) 
17 (55) 
11 (35) .261 
 
Family History in First Degree 
Relative 
Yes 
No 
20 (26) 
58 (74) 
10 (21) 
37 (79) 
10 (32) 
21 (68) .277 
 
High-Risk (Gail risk ≥ 20%) 
Yes 
No 
8 (10) 
70 (90) 
3 (6) 
44 (94) 
5 (16) 
26 (84) .254 
Data presented as frequency (%) 
Breast MRI prior to surgery, post MRI biopsy, genetic counseling, family history in first 
degree relative compared with Chi-square tests 
Genetic testing results and high-risk status compared with Fisher’s Exact test 
*significant p ≤ .05 
 
 
  
 72 
 
Table 4.3 
 
Clinical Characteristics of the Sample (n = 78) 
Clinical Characteristics  
 
Total 
Sample 
 
(n = 78) 
Breast 
Conserving 
Surgery 
 
(n = 47) 
Mastectomy 
with 
Contralateral 
Prophylactic 
Mastectomy 
 
(n = 31) p 
 
Tumor Size (cms.),  
mean (± SD) 1.5 ± 1.24 1.1 ± 0.67  2.2 ± 1.5 .000* 
 
Tumor Histology 
Ductal (In Situ or Invasive) 
Lobular (In Situ or Invasive) 
 
71 (91) 
7 (9) 
 
41 (87) 
6 (13) 
 
30 (97) 
1 (3) .233 
 
Lymph Node Status 
Positive 
Negative 
Not Applicable 
8 (10) 
58 (74) 
12 (15) 
2 (4) 
33 (70) 
12 (26) 
6 (19) 
25 (81) 
0 .134 
 
Estrogen Receptor 
Positive 
Negative 
 
74 (95) 
4 (5) 
 
45 (96) 
2 (4) 
29 (94) 
2 (7) 1.0 
 
Progesterone Receptor 
Positive 
Negative 
75 (96) 
4 (5) 
45 (96) 
2 (4) 
29 (94) 
1 (3) 1.0 
 
HER2-neu Receptor 
Positive 
Negative 
Not Applicable 
 
 
6 (8) 
56 (72) 
16 (21) 
 
 
3 (6) 
32 (68) 
12 (26) 
 
 
3 (10) 
24 (77) 
26 (81) 
 
 
 
 
1.0 
Data presented as frequency (%) 
Tumor size compared by independent t-test  
Histology, lymph node status, estrogen receptor status, progesterone receptor status and 
HER2-neu compared with Fisher’s Exact test 
*significant p ≤ .05 
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Table 4.4 
 
Properties of Study Scales and Subscales: Depression Anxiety Stress Scale (DASS), 
Impact of Events Scale (IES), Decisional Conflict Scale (DCS) 
     Range 
 n M SD α Potential Actual 
Scale/Subscale       
DASS 75 20.10 18.09 .96 0 - 126 0 - 75 
DASS 
Depression 
Subscale 
76 6.38 8.24 .95 0 - 42 0 - 40 
DASS Anxiety 
Subscale 78 5.44 6.26 .86 0 - 42 0 - 27 
DASS Stress 
Subscale 77 9.39 7.32 .91 0 - 42 0 - 25 
       
IES 77 28.20 18.54 .93 0-75 0 - 67 
IES Intrusion 
Subscale 77 13.52 9.49 .89 0-35 0-35 
IES Avoidance 
Subscale 78 14.59 10.17 .87 0-40 0-36 
       
DCS 78 9.10 12.62 .95 0-100 0-73.44 
DCS Informed 
Subscale 78 7.16 12.72 .89 0-100 0-66.67 
DCS Values 
Clarity Subscale 78 10.04 16.14 .93 0-100 0-75 
DCS Support 
Subscale 78 5.56 12.06 .92 0-100 0-75 
DCS Uncertainty 
Subscale 78 14.85 17.29 .67 0-100 0-75 
DCS Effective 
Decision 
Subscale 
78 8.17 13.60 .92 0-100 0-75 
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Table 4.5 
 
Distribution of Depression, Anxiety, and Stress Scores by Level of Symptom Severity (n = 
78) 
  
Depression 
 
Anxiety 
 
Stress 
 
Level* 
 
Range 
 
Frequency   
(Percent) 
 
Range 
 
Frequency  
(Percent) 
 
Range 
 
Frequency  
(Percent) 
 
Normal 
 
0 – 9 
 
62 (80) 
 
0 – 7 
 
56 (72) 
 
0 – 14 
 
58 (74) 
 
Mild 
 
10 – 13 
 
2   (3) 
 
8 – 9 
 
 6  (8) 
 
15 – 18 
 
6  (8) 
 
Moderate 
 
14 – 20 
 
6   (8) 
 
10 – 14 
 
 7  (9) 
 
19 – 25 
 
13  (17) 
 
Severe 
 
21 – 27 
 
4   (5) 
 
15 – 19 
 
 6  (8) 
 
26 – 33 
 
0 
 
Extremely 
Severe 
 
 
28 – 42 
 
2   (3) 
 
20 – 42 
 
 3  (4) 
 
34 – 42 
 
0 
* Lovibond and Lovibond (1995)  
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Table 4.6 
 
Comparison of Scores: Depression Anxiety Stress Scale (DASS) and Subscales, Impact of 
Events Scale (IES) and Subscales and Decisional Conflict Scale (DCS) and Subscales 
among Women Choosing Breast Conserving Surgery (BCS) or Mastectomy with 
Contralateral Prophylactic Mastectomy (CPM)   
Measure (range of potential scores) 
BCS 
 
        (n = 47) 
Mastectomy 
with CPM 
 
        (n = 31) p 
DASS Total (0-126) 18 (SD 17) 24 (SD 19) .587 
DASS Depression Subscale (0-42) 6 (SD 9) 7 (SD 9) .592 
DASS Anxiety Subscale (0-42) 4 (SD 5) 7 (SD 8)   .004* 
DASS Stress Subscale (0-42) 8 (SD 7) 11 (SD 8)  .345 
    
IES Total (0-75) 25 (SD 18) 33 (SD 9) .503 
IES Intrusion Subscale (0-35) 11 (SD 9) 17 (SD 10)   .006* 
IES Avoidance Subscale (0-40) 14 (SD 10) 16 (SD 11) .395 
    
DCS Total (0-100) 10 (SD 15) 8 (SD 8)   .021* 
DCS Informed Subscale (0-100) 8 (SD 14) 5 (SD 8) .183 
DCS Values Clarity Subscale (0-100) 7 (SD 12) 4 (SD 8)   .021* 
DCS Support (0-100) 7 (SD 14) 4 (SD 8)   .053* 
DCS Uncertainty (0-100) 13 (SD 19) 17 (SD 14) .199 
DCS Effective Decision (0-100) 10 (SD 16) 6 (SD 9)  .013* 
    
Mean (Standard Deviation)  
Independent sample t-test  
*significant p ≤ .05 
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Table 4.7 
  
Breast Surgery Beliefs and Expectation Scale (n = 77) 
 
Not At All 
Important 
Somewhat 
Important Important 
Very 
Important 
Keep my breast 14 (18) 37 (48) 17 (22) 9 (12) 
 
Minimize the chance of breast 
cancer coming back 0 2 (3) 12 (16) 63 (82) 
Avoid Radiation 24 (31) 19 (25) 18 (23) 16 (21) 
Minimize the length of treatment* 11 (14) 22 (29) 14 (18) 29 (38) 
Remove breast for peace of mind 25 (33) 14 (18) 12 (16) 26 (34) 
 
Avoid the need for future 
mammograms/breast screening 38 (49) 9 (12) 13 (17) 17 (22) 
Do as little surgery as possible 17 (22) 28 (36) 13 (17) 19 (25) 
Minimize the chance of dying of 
breast cancer 2 (3) 5 (7) 2 (3) 68 (88) 
Have the option to improve my 
breasts through reconstruction 36 (47) 12 (16) 8 (10) 21 (27) 
Values given as frequency (%) 
*missing data = 1 
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Table 4.8 
 
Breast Surgery Belief and Expectation Scale Factor Analysis with Varimax Rotation (n = 
77) 
Item 
 
Factors 
1 2 3 
BSBE5 
Remove breast for peace of mind 
 
.803 .354 -.194 
BSBE3 
Avoid Radiation 
 
.797  .266 
BSBE6 
Avoid the need for future mammograms/breast screening 
 
.706   
BSBE9 
Have the option to improve my breasts through 
reconstruction 
 
.511 .275  
BSBE2 
Minimize the chance of breast cancer coming back 
 
.157 .871  
BSBE8 
Minimize the chance of dying of breast cancer 
 
.125 .848 .105 
BSBE7 
Do as little surgery as possible 
 
.192  .806 
BSBE1 
Keep my breast 
 
-.182 .101 .747 
BSBE4 
Minimize the length of treatment 
 
.480  .537 
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Table 4.9 
 
Most Influential Information Source of Women Choosing BCS or Mastectomy with CPM   
Most Influential 
Information Source 
 
Total Sample 
 
(n = 78) 
BCS 
 
(n = 47) 
Mastectomy 
with CPM 
 
 (n = 31) p 
 
Physician  
Yes 
No 
Missing  
30 (39) 
32 (41) 
16 (21) 
25 (53) 
14 (30) 
8 (17) 
5 (16) 
18 (58) 
8 (26) .001* 
 
Spouse/Family 
Yes 
No 
Missing 
16 (21) 
46 (59) 
16 (21) 
6 (13) 
33 (70) 
8 (17) 
10 (32) 
13 (42) 
8 (74) .015* 
Data presented as frequency (%) 
Comparison by chi-square 
*significant p ≤ .05 
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Figure 4.1 
Sources of Information Identified by Women with Early Stage Breast Cancer Making Surgical Decisions (reported in %, n = 
78) 
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Figure 4.2 
Sources of Information Identified by Women Choosing Mastectomy with Contralateral Prophylactic Mastectomy (CPM) and 
Breast Conserving Surgery (BCS) (reported in %, n = 78) 
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CHAPTER FIVE: 
Conclusion 
 The essential basis of shared decision-making is a choice among options. The 
options are neither right nor wrong, they are different. Such is the case in clinical practice 
with early stage, unilateral breast cancer patients who are making choices among surgery 
options. The choices are quite different and are optimally discussed in a shared decision-
making process between patient and healthcare provider. The goal is a quality decision, 
based on personal values and on the best evidence (Ottawa Hospital Research Institute, 
2015). In an effort to study the decision making process among women with early stage 
breast cancer, this dissertation was undertaken.  
 Chapter Two of this dissertation is a psychometric evaluation of an anxiety 
measure. The Depression Anxiety Stress Scale (DASS), a valid and reliable measure in 
various settings, had not been tested with women recalled for false-positive 
mammograms. Women in the original study completed questionnaires including the 
DASS. In this secondary data analysis, the DASS Anxiety subscale was evaluated in a 
subset of 2672 women from the original study. Analysis supported the reliability and 
validity of the DASS anxiety subscale with women recalled for false-positive 
mammograms.   
Anxiety has been reported in women recalled for false-positive mammograms and 
in women who are diagnosed with breast cancer (Nelson et al., 2016; Pedersen et al., 
2010). In the breast cancer setting, levels of anxiety have been found to both be 
correlated and to not be correlated with surgery type (i.e. breast conserving surgery or 
mastectomy) when measured post-operatively (Lim, Devi, & Ang, 2011).  There is some 
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evidence of coincident anxiety during the decision-making process and elevated levels of 
anxiety in the preoperative time period have been consistently described in studies of 
women diagnosed with breast cancer (Epping-Jordan et al., 1999; Goel et al., 2001; 
Pedersen et al., 2010; Rakovitch et al., 2003).   
Chapter Three is a critical review of decisional conflict scales. This review was 
undertaken to evaluate decisional conflict scales for use during breast cancer surgical 
decision making. The background of scale development and psychometric properties of 
decision conflict scales were reported in this chapter. The Decisional Conflict Scale 
(DCS) has demonstrated reliability and validity overall but some variation in factor 
structure has been reported.  The DCS is widely used in research about medical decision-
making. The analysis from this chapter provided important information for the study 
described in Chapter Four. 
Chapter Four completes the dissertation with the report of a prospective, 
exploratory, cross-sectional, mixed-methods study. The study was designed to generate 
new knowledge about factors influencing preference for surgical choice among women 
with early stage breast cancer.  There has been a lack of prospective research on this 
topic.  Most of the research conducted to date has been retrospective reviews of large 
cancer database information.  Some retrospective surveys and interviews with patients 
have also been conducted. Prospective studies are needed to describe beliefs, 
expectations and emotions which may influence decisions as decision-making takes 
place.  
In the study described in Chapter Four, factors were compared between subgroups 
of women choosing breast conserving surgery (n = 47) and mastectomy with contralateral 
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prophylactic mastectomy (n = 31). There was significant difference between the groups 
regarding: age, employment, tumor size, completion of preoperative breast magnetic 
resonance imaging and genetic counseling. Women choosing mastectomy with CPM 
were younger, had larger tumors, and completed genetic counseling prior to surgery 
which is consistent with previous reports. Results from this study contradict previous 
work in which preoperative MRI has been predictive of bilateral mastectomy. In this 
study, women who completed preoperative breast MRI were more likely to choose breast 
conserving surgery.  Women who worked part- or full-time were more likely to choose 
bilateral mastectomy which is a new finding.  
Anxiety and breast-cancer specific distress were significantly higher among 
women choosing mastectomy with contralateral mastectomy. Decisional conflict was 
higher among women choosing breast conserving surgery. The significant differences 
between the groups for both anxiety and decisional conflict are new findings. A new 
scale, the Breast Surgery Beliefs and Expectations Scale was developed for use in this 
study to examine differences between the two groups. Factor analysis was completed and 
the resulting three factors were analyzed by subgroup. Significant differences between 
the two groups for all three factors were found. Information sources were similar between 
the groups but the surgeon was the most influential information source to women 
choosing breast conserving surgery and family was the most influential source for those 
choosing bilateral mastectomy.  This study provides evidence regarding the influence of 
factors such as anxiety, intrusive impact, surgery beliefs and expectations, and 
information sources in the decision-making process.  
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Appendix  
Study Packet 
 
 
 
#___________ 
 
 
 
 
 
 
 
 
Factors Influencing Preference for Surgical Choice among Women with 
Early Stage Breast Cancer 
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Demographic Questionnaire 
 
 
 
How old are you? ________ years 
 
 
Instructions: To each item, please circle the response that best describes you  
 
1.Race     
 
1. Caucasian (White)       
2. African-American    
3. Hispanic 
4. Asian 
5. American-Indian 
6. Alaskan-Indian 
7. Other _______________ 
 
4. Marital Status 
 
1. Married/Partnered 
2. Divorced/Separated/Single/Widowed 
 
2.Education: Circle the highest level of 
education completed 
 
1. Elementary 
2. High school 
3. College/University 
4. Graduate School 
 
5.Employment 
 
1. Employed Full or Part Time 
2. Other 
 
3.Household Income 
 
1. Less than $20,000 
2. $20,001 - $40,000 
3. $40,001 - $80,000 
4. More than $80,001 
 
6.Insurance 
 
1. No Insurance/Self Pay 
2. Medicaid 
3. Any commercial insurance (Anthem, Blue 
Grass Family Health, United, etc) 
4. Medicare with or without a supplement 
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Instructions:  To each item, please fill in the blanks or circle the response that best 
describes you  
 
Do you have a personal history of a genetic mutation that increases the risk of 
breast cancer (i.e. BRCA1 or BRCA2) 
 
1) Yes 
2) No 
3) I don’t know 
 
Has anyone ever told you that your lifetime risk of contracting Breast Cancer was 
higher than an average woman of your age? 
 
1) Yes 
2) No 
3) I don’t know 
 
If yes, please write in your percentage of lifetime risk for developing Breast Cancer  if 
you know it _____________% 
 
 
At what age did you experience menarche (first period)?_____________________ 
 
At what age was your first live birth?______________________________________ 
 
Prior to any biopsies for this breast cancer diagnosis, how many breast biopsies 
have you had? 
1) 0 
2) 1 
3) >1 
 
Have any of those biopsies prior to this diagnosis shown any of the following? 
Please circle any and all of previous biopsy findings 
1) ADH (Atypical Ductal Hyperplasia) 
2) ALH (Atypical Lobular Hyperplasia) 
3) LCIS (Lobular Carcinoma in Situ) 
4) DCIS (Ductal Carcinoma in Situ) 
5) Not Applicable/No biopsies prior to this diagnosis 
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Family History of Breast Cancer in First Degree Relatives 
 
Please circle “Yes” or “No” indicating any of your relatives who have been  
diagnosed with Breast Cancer 
 
Relative Diagnosed with Breast Cancer 
Parent (either mother or father) 
 
Yes          No 
 
Any one sister 
 
Yes          No 
 
More than one sister 
 
Yes          No 
 
Any one daughter 
 
Yes          No 
 
More than one daughter  
 
Yes          No 
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DAS S 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement 
applied to you over the past week.  There are no right or wrong answers.  Do not spend too much 
time on any statement. 
                                                     The rating scale is as follows: 
                                                           0  Did not apply to me at all 
                                         1  Applied to me to some degree, or some of the time 
                                                           2  Applied to me to a considerable degree, or a good part of time 
                                3  Applied to me very much, or most of the time 
1 I found myself getting upset by quite trivial things 0      1      2      3 
2 I was aware of dryness of my mouth 0      1      2      3 
3 I couldn't seem to experience any positive feeling at all 0      1      2      3 
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
0      1      2      3 
5 I just couldn't seem to get going 0      1      2      3 
6 I tended to over-react to situations 0      1      2      3 
7 I had a feeling of shakiness (eg, legs going to give way) 0      1      2      3 
8 I found it difficult to relax 0      1      2      3 
9 I found myself in situations that made me so anxious I was most 
relieved when they ended 
0      1      2      3 
10 I felt that I had nothing to look forward to 0      1      2      3 
11 I found myself getting upset rather easily 0      1      2      3 
12 I felt that I was using a lot of nervous energy 0      1      2      3 
13 I felt sad and depressed 0      1      2      3 
14 I found myself getting impatient when I was delayed in any way 
(eg, elevators, traffic lights, being kept waiting) 
0      1      2      3 
15 I had a feeling of faintness 0      1      2      3 
16 I felt that I had lost interest in just about everything 0      1      2      3 
17 I felt I wasn't worth much as a person 0      1      2      3 
18 I felt that I was rather touchy 0      1      2      3 
19 I perspired noticeably (eg, hands sweaty) in the absence of high 
temperatures or physical exertion 
0      1      2      3 
20 I felt scared without any good reason 0      1      2      3 
21 I felt that life wasn't worthwhile 0      1      2      3 
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                                               Reminder of the rating scale: 
                                                     0  Did not apply to me at all 
                              1  Applied to me to some degree, or some of the time 
                                                2  Applied to me to a considerable degree, or a good part of time 
                     3  Applied to me very much, or most of the time 
 
  22 I found it hard to wind down 0      1      2      3 
23 I had difficulty in swallowing 0      1      2      3 
24 I couldn't seem to get any enjoyment out of the things I did 0      1      2      3 
25 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
0      1      2      3 
26 I felt down-hearted and blue 0      1      2      3 
27 I found that I was very irritable 0      1      2      3 
28 I felt I was close to panic 0      1      2      3 
29 I found it hard to calm down after something upset me 0      1      2      3 
30 I feared that I would be "thrown" by some trivial but 
unfamiliar task 
0      1      2      3 
31 I was unable to become enthusiastic about anything 0      1      2      3 
32 I found it difficult to tolerate interruptions to what I was doing 0      1      2      3 
33 I was in a state of nervous tension 0      1      2      3 
34 I felt I was pretty worthless 0      1      2      3 
35 I was intolerant of anything that kept me from getting on with 
what I was doing 
0      1      2      3 
36 I felt terrified 0      1      2      3 
37 I could see nothing in the future to be hopeful about 0      1      2      3 
38 I felt that life was meaningless 0      1      2      3 
39 I found myself getting agitated 0      1      2      3 
40 I was worried about situations in which I might panic and make 
a fool of myself 
0      1      2      3 
41 I experienced trembling (eg, in the hands) 0      1      2      3 
42 I found it difficult to work up the initiative to do things 0      1      2      3 
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Impact of Event Scale 
Instructions: Please read each item, and then indicate how frequently those comments were true 
for you during the past 7 days with respect to your experience with breast cancer 
0 = Not at all, 1 = Rarely, 3 = Sometimes, 5 = Often 
 Not at all Rarely Sometimes Often 
 
1. I thought about it when I didn’t mean to 
 
0 1 3 5 
 
2. I avoided letting myself get upset when I 
thought about it or was reminded of it 
0 1 3 5 
 
3. I tried to remove it from my memory 
 
0 1 3 5 
4. I had trouble falling asleep or staying 
asleep because of pictures or thoughts 
about it that came into my mind 
0 1 3 5 
 
5. I had waves of strong feelings about it 
 
0 1 3 5 
 
6. I had dreams about it 
 
0 1 3 5 
 
7. I stayed away from reminders of it 
 
0 1 3 5 
 
8. I felt as if it hadn’t happened or wasn’t real 
 
0 1 3 5 
 
9. I tried not to talk about it 
 
0 1 3 5 
10. Pictures about it popped into my mind 0 1 3 
 
5 
 
 
11. Other things kept making me think about it 
 
0 1 3 5 
 
12. I was aware I still had a lot of feelings 
about it but I didn’t deal with them 
0 1 3 5 
 
13. I tried not to think about it 
 
0 1 3 5 
 
14. Any reminder brought back feelings about 
it 
 
0 1 3 5 
15. My feelings about it were kind of numb 0 1 3 5 
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Decisional Conflict 
 
A.  Which breast surgery option have you chosen?  Please check √ one. 
 Lumpectomy (Breast conserving surgery) 
 Mastectomy (Removal of one breast only) 
 Bilateral Mastectomy (Removal of both breasts) 
B. Considering the option you prefer, please answer the following questions: 
  
Strongly 
Agree 
 
Agree 
Neither 
Agree 
Nor 
Disagree 
 
Disagree 
 
Strongly 
Disagree 
1. I know which options are available to 
me.      
2. I know the benefits of each option.      
3. I know the risks and side effects of 
each option.      
4. I am clear about which benefits 
matter most to me.      
5. I am clear about which risks and side 
effects matter most to me.      
6. I am clear about which is more 
important to me (the benefits or the 
risks and side effects). 
     
7. I have enough support from others to 
make a choice.      
8. I am choosing without pressure from 
others.      
9. I have enough advice to make a 
choice.      
10. I am clear about the best choice for 
me.      
11. I feel sure about what to choose.      
12. This decision is easy for me to make.      
13. I feel I have made an informed 
choice.      
14. My decision shows what is important 
to me.      
15. I expect to stick with my decision.      
16. I am satisfied with my decision.      
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Breast Surgery Beliefs and Expectations 
 
Instructions: Circle the number that best indicates the importance of each item as you 
were making your decision about surgery. 
The rating scale is as follows: 
1 = Not at all Important or Not Applicable, 2 = Somewhat Important, 3 = Important, 4 = 
Very Important 
 
 
Not at all 
Important 
 
Somewhat 
Important 
 
 
Important 
 
Very 
Important 
 
Keep my breast 
 
1 2 3 4 
 
Minimize the chance of breast cancer 
coming back 
 
1 2 3 4 
 
Avoid Radiation 
 
1 2 3 4 
 
Minimize the length of treatment 
 
1 2 3 4 
 
Remove breast for peace of mind 
 
1 2 3 4 
 
Avoid the need for future 
mammograms/breast screening 
 
1 2 3 4 
 
Do as little surgery as possible 
 
1 2 3 4 
 
Minimize the chance of dying of breast 
cancer 
 
1 2 3 4 
 
Have the option to improve my breasts 
through reconstruction 
 
1 2 3 4 
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Breast Surgery Beliefs and Expectations 
  
Please rank the following 9 factors in order of importance to you as you were making 
your surgical choice. 1 = Most Important, 9 = Least Important 
 
__________ 
 
Keep my breast 
 
__________ 
 
Minimize the chance of breast cancer coming back 
 
__________ 
 
Avoid Radiation 
 
__________ 
 
Minimize the length of treatment 
 
__________ 
 
Remove breast for peace of mind 
 
__________ 
 
Avoid the need for future mammograms/breast screening 
 
__________ 
 
Do as little surgery as possible 
 
__________ 
 
Minimize the chance of dying of breast cancer 
 
__________ 
 
Have the option to improve my breasts through reconstruction 
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Sources of Information 
 
Please check all of the following which/who served as a source of information to you as 
you considered your breast cancer surgical decision 
 
_____Surgeon 
 
_____Gynecologist 
 
_____Primary Care Provider  
 
_____Mammography/Breast Imaging Physician 
 
_____Nurse Navigator 
 
_____Mammography/Breast Imaging Nurse 
 
_____Spouse/Partner 
 
_____Family Member(s) 
 
_____Friend(s) 
 
_____Support Group Members 
 
_____Counselor/Therapist 
 
_____Spiritual/Religious Advisor 
 
_____Internet/Web 
 
_____Informational Brochure/Written Materials 
 
_____Other (please specify)___________________________________________ 
 
 
 
 
 
***Of the choices you marked above, please indicate which/who was the most influential 
in your decision.  Please circle that response. 
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Comment 
 
In your own words, please describe the reason for your surgical choice: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Did your initial intent regarding surgery match your final decision? 
Please check yes or no: 
 
 Yes 
 
 No 
 
 
 
 
 
 
 
Thank you! 
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